Document
false--12-31Q320190001289848P5DP20D0.010.015000000005000000002511473925337297305P13YP5YP5YP6YP3YP3YP3YP5YP1YP3MP1YP5Y25682882416530 0001289848 2019-01-01 2019-09-30 0001289848 2019-10-22 0001289848 2018-12-31 0001289848 2019-09-30 0001289848 2018-07-01 2018-09-30 0001289848 2018-01-01 2018-09-30 0001289848 2019-07-01 2019-09-30 0001289848 us-gaap:CommonStockMember 2018-06-30 0001289848 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0001289848 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001289848 us-gaap:CommonStockMember 2019-09-30 0001289848 us-gaap:CommonStockMember 2018-09-30 0001289848 us-gaap:CommonStockMember 2019-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001289848 us-gaap:TreasuryStockMember 2018-06-30 0001289848 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0001289848 2019-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001289848 us-gaap:RetainedEarningsMember 2018-09-30 0001289848 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0001289848 us-gaap:TreasuryStockMember 2019-09-30 0001289848 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0001289848 us-gaap:TreasuryStockMember 2018-09-30 0001289848 2018-09-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0001289848 us-gaap:RetainedEarningsMember 2018-06-30 0001289848 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001289848 us-gaap:RetainedEarningsMember 2019-06-30 0001289848 us-gaap:RetainedEarningsMember 2019-09-30 0001289848 2018-06-30 0001289848 us-gaap:TreasuryStockMember 2019-06-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0001289848 us-gaap:TreasuryStockMember 2017-12-31 0001289848 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001289848 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001289848 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001289848 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001289848 us-gaap:RetainedEarningsMember 2017-12-31 0001289848 us-gaap:TreasuryStockMember 2018-12-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001289848 us-gaap:TreasuryStockMember 2019-01-01 2019-09-30 0001289848 us-gaap:CommonStockMember 2018-12-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001289848 us-gaap:RetainedEarningsMember 2018-12-31 0001289848 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001289848 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0001289848 2017-12-31 0001289848 us-gaap:CommonStockMember 2017-12-31 0001289848 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-09-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0001289848 2019-01-01 0001289848 us-gaap:OtherLiabilitiesMember 2019-01-01 2019-01-01 0001289848 hurn:DeferredrentcreditnoncurrentMember 2019-01-01 2019-01-01 0001289848 hurn:OperatingleaseliabilitycurrentMember 2019-01-01 2019-01-01 0001289848 hurn:OperatingleaserightofuseassetMember 2019-01-01 2019-01-01 0001289848 us-gaap:AccruedLiabilitiesMember 2019-01-01 2019-01-01 0001289848 hurn:OperatingleaseliabilitynoncurrentMember 2019-01-01 2019-01-01 0001289848 us-gaap:OffMarketFavorableLeaseMember 2018-12-31 0001289848 us-gaap:OffMarketFavorableLeaseMember 2019-09-30 0001289848 us-gaap:NoncompeteAgreementsMember 2018-12-31 0001289848 us-gaap:CustomerContractsMember 2019-01-01 2019-09-30 0001289848 us-gaap:CustomerContractsMember 2018-12-31 0001289848 us-gaap:NoncompeteAgreementsMember 2019-09-30 0001289848 us-gaap:CustomerRelationshipsMember 2018-12-31 0001289848 us-gaap:TradeNamesMember 2018-12-31 0001289848 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-09-30 0001289848 us-gaap:OffMarketFavorableLeaseMember 2019-01-01 2019-09-30 0001289848 us-gaap:CustomerContractsMember 2019-09-30 0001289848 us-gaap:CustomerRelationshipsMember 2019-09-30 0001289848 us-gaap:TechnologyBasedIntangibleAssetsMember 2018-12-31 0001289848 us-gaap:TradeNamesMember 2019-09-30 0001289848 hurn:EducationMember 2019-09-30 0001289848 us-gaap:HealthCareMember 2018-12-31 0001289848 hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember 2018-12-31 0001289848 hurn:EducationMember 2018-12-31 0001289848 us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember 2019-09-30 0001289848 us-gaap:HealthCareMember 2019-09-30 0001289848 hurn:EducationMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-01 2019-09-30 0001289848 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember us-gaap:TradeNamesMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2019-01-01 2019-09-30 0001289848 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2019-01-01 2019-09-30 0001289848 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-01 2019-09-30 0001289848 srt:MinimumMember us-gaap:TradeNamesMember 2019-01-01 2019-09-30 0001289848 us-gaap:RestructuringChargesMember 2019-01-01 2019-09-30 0001289848 us-gaap:RestructuringChargesMember 2019-07-01 2019-09-30 0001289848 2019-10-01 2019-10-31 0001289848 us-gaap:LeaseholdImprovementsMember 2019-01-01 2019-09-30 0001289848 us-gaap:SegmentDiscontinuedOperationsMember hurn:HuronLegalMember 2019-07-01 2019-09-30 0001289848 us-gaap:SegmentDiscontinuedOperationsMember hurn:HuronLegalMember 2019-01-01 2019-09-30 0001289848 hurn:OperatingleaserightofuseassetMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember 2019-09-30 0001289848 srt:MinimumMember 2019-09-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2018-01-01 2018-09-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2019-01-01 2019-09-30 0001289848 hurn:ReleaseofAllowanceMember 2018-07-01 2018-09-30 0001289848 hurn:ReleaseofAllowanceMember 2019-01-01 2019-09-30 0001289848 2021-01-01 2019-09-30 0001289848 2019-10-01 2019-09-30 0001289848 hurn:ReleaseofAllowanceMember 2019-07-01 2019-09-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2018-07-01 2018-09-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2019-07-01 2019-09-30 0001289848 2020-01-01 2019-09-30 0001289848 hurn:ReleaseofAllowanceMember 2018-01-01 2018-09-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-09-30 0001289848 us-gaap:WarrantMember 2018-01-01 2018-09-30 0001289848 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-09-30 0001289848 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001289848 us-gaap:RestrictedStockMember 2018-01-01 2018-09-30 0001289848 hurn:ShareRepurchaseProgramMember 2019-09-30 0001289848 us-gaap:ConvertibleDebtMember 2018-07-01 2018-09-30 0001289848 us-gaap:ConvertibleDebtMember 2018-01-01 2018-09-30 0001289848 us-gaap:ConvertibleDebtMember 2019-07-01 2019-09-30 0001289848 us-gaap:ConvertibleDebtMember 2019-01-01 2019-09-30 0001289848 us-gaap:ConvertibleDebtMember 2018-12-31 0001289848 hurn:SeniorSecuredCreditFacilityMember 2019-09-30 0001289848 us-gaap:ConvertibleDebtMember 2019-09-30 0001289848 hurn:PromissoryNotedue2024Member 2018-12-31 0001289848 hurn:PromissoryNotedue2024Member 2019-09-30 0001289848 hurn:SeniorSecuredCreditFacilityMember 2018-12-31 0001289848 us-gaap:ConvertibleDebtMember 2014-09-30 2014-09-30 0001289848 hurn:SeniorSecuredCreditFacilityMember 2015-03-31 2015-03-31 0001289848 srt:MaximumMember hurn:SeniorSecuredCreditFacilityMember us-gaap:BaseRateMember 2015-03-31 2015-03-31 0001289848 us-gaap:WarrantMember 2014-09-30 2014-09-30 0001289848 srt:AircraftTypeMember 2019-09-30 0001289848 srt:MaximumMember hurn:SeniorSecuredCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-03-31 2015-03-31 0001289848 us-gaap:WarrantMember 2014-09-30 0001289848 srt:MinimumMember hurn:SeniorSecuredCreditFacilityMember us-gaap:BaseRateMember 2015-03-31 2015-03-31 0001289848 hurn:PromissoryNotedue2024Member 2017-06-30 0001289848 srt:MaximumMember us-gaap:ConvertibleDebtMember 2014-09-30 0001289848 us-gaap:ConvertibleDebtMember 2014-09-30 0001289848 hurn:SeniorSecuredCreditFacilityMember 2015-03-31 0001289848 us-gaap:ConvertibleDebtMember 2019-10-01 2019-10-31 0001289848 srt:MinimumMember us-gaap:ConvertibleDebtMember 2014-09-30 0001289848 hurn:NoteHedgeMember 2014-09-30 2014-09-30 0001289848 hurn:SeniorSecuredCreditFacilityMember 2015-01-01 2015-03-31 0001289848 srt:MinimumMember us-gaap:ConvertibleDebtMember 2014-09-30 2014-09-30 0001289848 hurn:SeniorSecuredCreditFacilityMember 2019-10-01 0001289848 hurn:PromissoryNotedue2024Member 2017-06-30 2017-06-30 0001289848 hurn:NoteHedgeMember 2014-09-30 0001289848 srt:MinimumMember hurn:SeniorSecuredCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2015-03-31 2015-03-31 0001289848 srt:AircraftTypeMember 2018-12-31 0001289848 hurn:ContingentConsiderationLiabilityMember 2019-01-01 2019-09-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-09-30 0001289848 srt:MaximumMember us-gaap:ConvertibleDebtMember 2014-09-30 2014-09-30 0001289848 us-gaap:EmployeeSeveranceMember 2019-01-01 2019-09-30 0001289848 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-01-01 0001289848 us-gaap:EmployeeSeveranceMember 2019-09-30 0001289848 hurn:OfficeSpaceReductionsMember 2018-12-31 0001289848 us-gaap:AccountingStandardsUpdate201602Member hurn:OfficeSpaceReductionsMember 2019-01-01 2019-01-01 0001289848 us-gaap:EmployeeSeveranceMember 2019-01-01 0001289848 us-gaap:AccountingStandardsUpdate201602Member us-gaap:EmployeeSeveranceMember 2019-01-01 2019-01-01 0001289848 hurn:OfficeSpaceReductionsMember 2019-01-01 0001289848 us-gaap:EmployeeSeveranceMember 2018-12-31 0001289848 hurn:OfficeSpaceReductionsMember 2019-01-01 2019-09-30 0001289848 hurn:OfficeSpaceReductionsMember 2019-09-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:SanFranciscoCAMember 2018-01-01 2018-09-30 0001289848 us-gaap:EmployeeSeveranceMember us-gaap:CorporateNonSegmentMember 2019-01-01 2019-09-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:SanFranciscoCAMember 2018-07-01 2018-09-30 0001289848 us-gaap:OtherRestructuringMember hurn:BusinessAdvisoryMember 2018-04-01 2018-06-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:MiddletonWisconsinMember 2018-04-01 2018-06-30 0001289848 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-09-30 0001289848 us-gaap:MiddleEastMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:LakeOswegoOregonMember 2019-01-01 2019-09-30 0001289848 us-gaap:EmployeeSeveranceMember 2018-01-01 2018-09-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:MiddletonWisconsinMember 2019-01-01 2019-09-30 0001289848 hurn:OfficeSpaceReductionsMember hurn:HoustonTexasMember 2019-01-01 2019-09-30 0001289848 us-gaap:OtherNoncurrentAssetsMember 2018-12-31 0001289848 us-gaap:OtherNoncurrentLiabilitiesMember 2019-09-30 0001289848 us-gaap:OtherNoncurrentLiabilitiesMember 2018-12-31 0001289848 us-gaap:OtherNoncurrentAssetsMember 2019-09-30 0001289848 us-gaap:AccruedLiabilitiesMember 2019-09-30 0001289848 us-gaap:AccruedLiabilitiesMember 2018-12-31 0001289848 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-09-30 0001289848 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2018-12-31 0001289848 2017-06-22 2017-06-22 0001289848 2017-06-22 0001289848 us-gaap:ConvertibleDebtSecuritiesMember hurn:ShorelightHoldingsLlcMember 2019-09-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember hurn:ShorelightHoldingsLlcMember 2019-01-01 2019-09-30 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hurn:DeferredCompensationPlanAssetsMember 2019-09-30 0001289848 us-gaap:FairValueInputsLevel3Member hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember hurn:DeferredCompensationPlanAssetsMember 2018-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember hurn:DeferredCompensationPlanAssetsMember 2018-12-31 0001289848 hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2019-09-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2019-09-30 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2018-12-31 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember hurn:DeferredCompensationPlanAssetsMember 2019-09-30 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:ConvertibleDebtSecuritiesMember 2018-12-31 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:ForeignCurrencyGainLossMember hurn:ContingentConsiderationLiabilityMember 2019-01-01 2019-09-30 0001289848 hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2019-09-30 0001289848 us-gaap:ForeignCountryMember 2018-07-01 2018-09-30 0001289848 us-gaap:DomesticCountryMember 2018-07-01 2018-09-30 0001289848 us-gaap:DomesticCountryMember 2019-07-01 2019-09-30 0001289848 hurn:SharebasedCompensationMember 2018-01-01 2018-09-30 0001289848 2018-04-01 2018-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2018-01-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2019-07-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2018-07-01 2018-09-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember 2018-01-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember 2018-07-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 us-gaap:OperatingSegmentsMember 2019-01-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 hurn:EducationMember us-gaap:TransferredAtPointInTimeMember 2019-07-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:PerformancebasedMember 2019-07-01 2019-09-30 0001289848 hurn:PerformancebasedMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:EducationMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember 2019-07-01 2019-09-30 0001289848 us-gaap:TransferredOverTimeMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 us-gaap:TransferredAtPointInTimeMember 2019-07-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredOverTimeMember 2019-07-01 2019-09-30 0001289848 hurn:PerformancebasedMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember 2019-07-01 2019-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredOverTimeMember 2019-07-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 hurn:PerformancebasedMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredAtPointInTimeMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember 2019-07-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredAtPointInTimeMember 2019-07-01 2019-09-30 0001289848 us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember us-gaap:HealthCareMember 2019-07-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:EducationMember us-gaap:TransferredOverTimeMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember 2019-07-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:EducationMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:BusinessAdvisoryMember 2019-07-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-09-30 0001289848 us-gaap:TransferredOverTimeMember 2019-01-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember 2019-01-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 hurn:PerformancebasedMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeEquivalentsMember 2019-01-01 2019-09-30 0001289848 hurn:PerformancebasedMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 hurn:EducationMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:EducationMember 2019-01-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2019-01-01 2019-09-30 0001289848 hurn:PerformancebasedMember 2019-01-01 2019-09-30 0001289848 hurn:PerformancebasedMember us-gaap:HealthCareMember 2019-01-01 2019-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredOverTimeMember 2019-01-01 2019-09-30 0001289848 hurn:FulltimeBillableConsultantsMember 2019-01-01 2019-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:BusinessAdvisoryMember 2019-01-01 2019-09-30 0001289848 us-gaap:FixedPriceContractMember 2019-01-01 2019-09-30 0001289848 hurn:EducationMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-09-30 0001289848 hurn:EducationMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 hurn:PerformancebasedMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2018-01-01 2018-09-30 0001289848 hurn:PerformancebasedMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 hurn:PerformancebasedMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 hurn:EducationMember us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember 2018-01-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember 2018-01-01 2018-09-30 0001289848 hurn:EducationMember us-gaap:TransferredOverTimeMember 2018-01-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0001289848 hurn:PerformancebasedMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember 2018-01-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:BusinessAdvisoryMember 2018-01-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember 2018-01-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:EducationMember 2018-01-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember us-gaap:HealthCareMember 2018-01-01 2018-09-30 0001289848 us-gaap:TransferredAtPointInTimeMember 2018-01-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember 2018-07-01 2018-09-30 0001289848 hurn:EducationMember us-gaap:TransferredAtPointInTimeMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember 2018-07-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember 2018-07-01 2018-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredOverTimeMember 2018-07-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 us-gaap:TransferredOverTimeMember 2018-07-01 2018-09-30 0001289848 us-gaap:TransferredAtPointInTimeMember 2018-07-01 2018-09-30 0001289848 us-gaap:TimeAndMaterialsContractMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 hurn:EducationMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredOverTimeMember 2018-07-01 2018-09-30 0001289848 hurn:PerformancebasedMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeBillableConsultantsMember us-gaap:HealthCareMember 2018-07-01 2018-09-30 0001289848 hurn:PerformancebasedMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 hurn:EducationMember us-gaap:TransferredOverTimeMember 2018-07-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 hurn:FulltimeEquivalentsMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 hurn:BusinessAdvisoryMember us-gaap:TransferredAtPointInTimeMember 2018-07-01 2018-09-30 0001289848 hurn:PerformancebasedMember hurn:BusinessAdvisoryMember 2018-07-01 2018-09-30 0001289848 us-gaap:SoftwareServiceSupportAndMaintenanceArrangementMember hurn:EducationMember 2018-07-01 2018-09-30 0001289848 hurn:PerformancebasedMember 2018-07-01 2018-09-30 0001289848 us-gaap:FixedPriceContractMember 2018-07-01 2018-09-30 0001289848 us-gaap:HealthCareMember us-gaap:TransferredAtPointInTimeMember 2018-07-01 2018-09-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares hurn:Segment
Table of Contents




 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
 
FORM 10-Q 
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2019
OR 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 000-50976 
 
HURON CONSULTING GROUP INC.
(Exact name of registrant as specified in its charter)
 
 
Delaware
 
01-0666114
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification Number)
550 West Van Buren Street
Chicago, Illinois
60607
(Address of principal executive offices)
(Zip Code)
(312) 583-8700
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
HURN
NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-accelerated Filer
Smaller Reporting 
Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 22, 2019, 22,913,192 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.
 


Table of Contents




Huron Consulting Group Inc.
HURON CONSULTING GROUP INC.
INDEX

 
 
Page
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
Item 5.
 
 
 
Item 6.
 
 



Table of Contents




PART I - FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited) 
 
September 30,
2019
 
December 31,
2018
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
49,410

 
$
33,107

Receivables from clients, net
116,318

 
109,677

Unbilled services, net
99,784

 
69,613

Income tax receivable
713

 
6,612

Prepaid expenses and other current assets
14,211

 
13,922

Total current assets
280,436

 
232,931

Property and equipment, net
39,972

 
40,374

Deferred income taxes, net
1,108

 
2,153

Long-term investment
60,943

 
50,429

Operating lease right-of-use assets
52,342

 

Other non-current assets
45,005

 
30,525

Intangible assets, net
36,141

 
47,857

Goodwill
645,986

 
645,263

Total assets
$
1,161,933

 
$
1,049,532

Liabilities and stockholders’ equity
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
10,440

 
$
10,020

Accrued expenses and other current liabilities
22,719

 
17,207

Accrued payroll and related benefits
108,111

 
109,825

Accrued contingent consideration for business acquisitions

 
9,991

Current maturities of long-term debt
250,525

 
243,132

Current maturities of operating lease liabilities
10,529

 

Deferred revenues
31,224

 
28,130

Total current liabilities
433,548

 
418,305

Non-current liabilities:
 
 
 
Deferred compensation and other liabilities
26,308

 
20,875

Accrued contingent consideration for business acquisitions, net of current portion

 
1,450

Long-term debt, net of current portion
53,457

 
53,853

Operating lease liabilities, net of current portion
59,460

 

Deferred lease incentives

 
13,693

Deferred income taxes, net
1,603

 
732

Total non-current liabilities
140,828

 
90,603

Commitments and contingencies

 

Stockholders’ equity
 
 
 
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,337,297 and 25,114,739 shares issued at September 30, 2019 and December 31, 2018, respectively
248

 
244

Treasury stock, at cost, 2,416,530 and 2,568,288 shares at September 30, 2019 and December 31, 2018, respectively
(128,048
)
 
(124,794
)
Additional paid-in capital
469,257

 
452,573

Retained earnings
223,536

 
196,106

Accumulated other comprehensive income
22,564

 
16,495

Total stockholders’ equity
587,557

 
540,624

Total liabilities and stockholders’ equity
$
1,161,933

 
$
1,049,532

The accompanying notes are an integral part of the consolidated financial statements.

1

Table of Contents




HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME
(In thousands, except per share amounts)
(Unaudited) 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Revenues and reimbursable expenses:
 
 
 
 
 
 
 
Revenues
$
219,289

 
$
198,448

 
$
644,488

 
$
589,671

Reimbursable expenses
23,636

 
21,296

 
65,787

 
59,648

Total revenues and reimbursable expenses
242,925

 
219,744

 
710,275

 
649,319

Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses):
 
 
 
 
 
 
 
Direct costs
143,034

 
128,596

 
422,442

 
388,956

Amortization of intangible assets and software development costs
1,162

 
1,009

 
3,450

 
3,195

Reimbursable expenses
23,571

 
21,246

 
65,897

 
59,710

Total direct costs and reimbursable expenses
167,767

 
150,851

 
491,789

 
451,861

Operating expenses and other losses (gains), net
 
 
 
 
 
 
 
Selling, general and administrative expenses
48,123

 
45,915

 
151,409

 
138,481

Restructuring charges
127

 
(31
)
 
2,156

 
2,665

Litigation and other losses (gains), net
(630
)
 
887

 
(1,571
)
 
(4,990
)
Depreciation and amortization
6,962

 
8,561

 
21,285

 
26,281

Total operating expenses and other losses (gains), net
54,582

 
55,332

 
173,279

 
162,437

Operating income
20,576

 
13,561

 
45,207

 
35,021

Other income (expense), net:
 
 
 
 
 
 
 
Interest expense, net of interest income
(4,374
)
 
(4,628
)
 
(13,156
)
 
(14,636
)
Other income (expense), net
(82
)
 
707

 
2,830

 
(5,131
)
Total other expense, net
(4,456
)
 
(3,921
)
 
(10,326
)
 
(19,767
)
Income from continuing operations before taxes
16,120

 
9,640

 
34,881

 
15,254

Income tax expense
2,414

 
1,391

 
7,256

 
4,365

Net income from continuing operations
13,706

 
8,249

 
27,625

 
10,889

Income (loss) from discontinued operations, net of tax
(52
)
 
228

 
(195
)
 
(304
)
Net income
$
13,654

 
$
8,477

 
$
27,430

 
$
10,585

Net earnings per basic share:
 
 
 
 
 
 
 
Net income from continuing operations
$
0.62

 
$
0.38

 
$
1.26

 
$
0.50

Income (loss) from discontinued operations, net of tax

 
0.01

 
(0.01
)
 
(0.01
)
Net income
$
0.62

 
$
0.39

 
$
1.25

 
$
0.49

Net earnings per diluted share:
 
 
 
 
 
 
 
Net income from continuing operations
$
0.61

 
$
0.37

 
$
1.23

 
$
0.50

Income (loss) from discontinued operations, net of tax

 
0.01

 
(0.01
)
 
(0.02
)
Net income
$
0.61

 
$
0.38

 
$
1.22

 
$
0.48

Weighted average shares used in calculating earnings per share:
 
 
 
 
 
 
 
Basic
22,052

 
21,745

 
21,973

 
21,683

Diluted
22,561

 
22,110

 
22,425

 
21,947

Comprehensive income:
 
 
 
 
 
 
 
Net income
$
13,654

 
$
8,477

 
$
27,430

 
$
10,585

Foreign currency translation adjustments, net of tax
(630
)
 
(579
)
 
(673
)
 
(1,499
)
Unrealized gain (loss) on investment, net of tax
1,168

 
(852
)
 
7,740

 
4,473

Unrealized gain (loss) on cash flow hedging instruments, net of tax
(149
)
 
206

 
(998
)
 
821

Other comprehensive income (loss)
389

 
(1,225
)
 
6,069

 
3,795

Comprehensive income
$
14,043

 
$
7,252

 
$
33,499

 
$
14,380

The accompanying notes are an integral part of the consolidated financial statements.

2

Table of Contents




HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share amounts)
(Unaudited)
 
Three Months Ended September 30,
 
Common Stock
 
Treasury Stock
 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income
 
Stockholders’
Equity
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Balance at June 30, 2019
24,711,193

 
$
247

 
(2,742,826
)
 
$
(127,133
)
 
$
463,190

 
$
209,882

 
$
22,175

 
$
568,361

Comprehensive income
 
 
 
 
 
 
 
 
 
 
13,654

 
389

 
14,043

Issuance of common stock in connection with:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted stock awards, net of cancellations
58,164

 
1

 
(3,741
)
 
(169
)
 
168

 
 
 
 
 

Exercise of stock options
10,000

 

 
 
 
 
 
235

 
 
 
 
 
235

Share-based compensation
 
 
 
 
 
 
 
 
5,664

 
 
 
 
 
5,664

Shares redeemed for employee tax withholdings
 
 
 
 
(12,657
)
 
(746
)
 
 
 
 
 
 
 
(746
)
Balance at September 30, 2019
24,779,357

 
$
248

 
(2,759,224
)
 
$
(128,048
)
 
$
469,257

 
$
223,536

 
$
22,564

 
$
587,557

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at June 30, 2018
24,325,302

 
$
244


(2,633,755
)

$
(123,215
)

$
441,813


$
184,507


$
15,390


$
518,739

Comprehensive income
 
 
 
 
 
 
 
 
 
 
8,477

 
(1,225
)
 
7,252

Issuance of common stock in connection with:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted stock awards, net of cancellations
45,485

 

 
(13,688
)
 
(583
)
 
583

 
 
 
 
 

Exercise of stock options
10,000

 

 
 
 
 
 
234

 
 
 
 
 
234

Share-based compensation
 
 
 
 
 
 
 
 
4,019

 
 
 
 
 
4,019

Shares redeemed for employee tax withholdings
 
 
 
 
(8,241
)
 
(371
)
 
 
 
 
 
 
 
(371
)
Balance at September 30, 2018
24,380,787

 
$
244

 
(2,655,684
)
 
$
(124,169
)
 
$
446,649

 
$
192,984

 
$
14,165

 
$
529,873

 
Nine Months Ended September 30,
 
Common Stock
 
Treasury Stock
 
Additional
Paid-In
Capital
 
Retained
Earnings
 
Accumulated Other
Comprehensive
Income
 
Stockholders’
Equity
 
Shares
 
Amount
 
Shares
 
Amount
 
 
 
 
Balance at December 31, 2018
24,418,252

 
$
244

 
(2,671,962
)
 
$
(124,794
)
 
$
452,573

 
$
196,106

 
$
16,495

 
$
540,624

Comprehensive income
 
 
 
 
 
 
 
 
 
 
27,430

 
6,069

 
33,499

Issuance of common stock in connection with:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted stock awards, net of cancellations
331,105

 
4

 
21,433

 
1,952

 
(1,956
)
 
 
 
 
 

Exercise of stock options
30,000

 

 
 
 
 
 
703

 
 
 
 
 
703

Share-based compensation
 
 
 
 
 
 
 
 
17,937

 
 
 
 
 
17,937

Shares redeemed for employee tax withholdings
 
 
 
 
(108,695
)
 
(5,206
)
 
 
 
 
 
 
 
(5,206
)
Balance at September 30, 2019
24,779,357

 
$
248

 
(2,759,224
)
 
$
(128,048
)
 
$
469,257

 
$
223,536

 
$
22,564

 
$
587,557

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2017
24,098,822

 
$
241

 
(2,591,135
)
 
$
(121,994
)
 
$
434,256

 
$
180,443

 
$
10,370

 
$
503,316

Comprehensive income
 
 
 
 
 
 
 
 
 
 
10,585

 
3,795

 
14,380

Issuance of common stock in connection with:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restricted stock awards, net of cancellations
251,965

 
3

 
20,407

 
916

 
(919
)
 
 
 
 
 

Exercise of stock options
30,000

 

 
 
 
 
 
703

 
 
 
 
 
703

Share-based compensation
 
 
 
 
 
 
 
 
12,609

 
 
 
 
 
12,609

Shares redeemed for employee tax withholdings
 
 
 
 
(84,956
)
 
(3,091
)
 
 
 

 
 
 
(3,091
)
Cumulative-effect adjustment from adoption of ASC 606
 
 
 
 
 
 
 
 
 
 
1,956

 
 
 
1,956

Balance at September 30, 2018
24,380,787

 
$
244

 
(2,655,684
)
 
$
(124,169
)
 
$
446,649

 
$
192,984

 
$
14,165

 
$
529,873

The accompanying notes are an integral part of the consolidated financial statements.

3

Table of Contents




HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
Nine Months Ended
September 30,
 
2019
 
2018
Cash flows from operating activities:
 
 
 
Net income
$
27,430

 
$
10,585

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
31,823

 
29,965

Lease impairment charge
805

 

Share-based compensation
18,094

 
12,840

Amortization of debt discount and issuance costs
8,066

 
7,721

Allowances for doubtful accounts and unbilled services
191

 
573

Deferred income taxes
(262
)
 
179

Loss on sale of business

 
5,863

Change in fair value of contingent consideration liabilities
(1,506
)
 
(2,463
)
Changes in operating assets and liabilities, net of acquisitions and divestiture:
 
 
 
(Increase) decrease in receivables from clients, net
(6,817
)
 
(9,103
)
(Increase) decrease in unbilled services, net
(30,163
)
 
(16,714
)
(Increase) decrease in current income tax receivable / payable, net
10,561

 
1,400

(Increase) decrease in other assets
(4,160
)
 
(3,768
)
Increase (decrease) in accounts payable and other liabilities
(3,565
)
 
186

Increase (decrease) in accrued payroll and related benefits
(1,850
)
 
9,445

Increase (decrease) in deferred revenues
3,098

 
2,158

Net cash provided by operating activities
51,745

 
48,867

Cash flows from investing activities:
 
 
 
Purchases of property and equipment, net
(10,024
)
 
(6,662
)
Investment in life insurance policies
(4,434
)
 
(1,689
)
Purchases of businesses
(2,500
)
 
(215
)
Capitalization of internally developed software costs
(7,462
)
 
(3,611
)
Proceeds from note receivable

 
1,040

Divestiture of business

 
(2,359
)
Net cash used in investing activities
(24,420
)

(13,496
)
Cash flows from financing activities:
 
 
 
Proceeds from exercise of stock options
703

 
703

Shares redeemed for employee tax withholdings
(5,206
)
 
(3,091
)
Proceeds from borrowings under credit facility
105,500

 
179,800

Repayments of debt
(105,885
)
 
(213,674
)
Payments for debt issuance costs
(1,498
)
 
(1,385
)
Payments of contingent consideration liabilities
(4,674
)
 
(5,494
)
Net cash used in financing activities
(11,060
)
 
(43,141
)
Effect of exchange rate changes on cash
38

 
(114
)
Net increase (decrease) in cash and cash equivalents
16,303

 
(7,884
)
Cash and cash equivalents at beginning of the period
33,107

 
16,909

Cash and cash equivalents at end of the period
$
49,410

 
$
9,025

Supplemental disclosure of cash flow information:
 
 
 
Non-cash investing and financing activities:
 
 
 
Property and equipment expenditures and capitalized software included in accounts payable and accrued expenses
$
3,085

 
$
1,500

Contingent consideration related to business acquisition
$

 
$
212

The accompanying notes are an integral part of the consolidated financial statements.

4

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)


1. Description of Business
Huron is a global consultancy that helps clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with clients to develop strategies and implement solutions that enable the transformative change our clients need to own their future.
2. Basis of Presentation and Significant Accounting Policies
The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and nine months ended September 30, 2019 and 2018. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2018 included in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q for the periods ended March 31, 2019 and June 30, 2019. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
On January 1, 2019, we adopted Accounting Standard Update ("ASU") 2016-02, Leases. Below is an update to our lease accounting policy as a result of the adoption. Refer to Note 3 "New Accounting Pronouncements" for additional information on the adoption of ASU 2016-02.
Leases
We determine if an arrangement contains a lease and the classification of such lease at inception. As of September 30, 2019, all of our material leases are classified as operating leases; we have not entered into any material finance leases. For all operating leases with an initial term greater than 12 months, we recognize an operating lease right-of-use ("ROU") asset and operating lease liability. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term.
Operating lease ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date and provided by the administrative agent for our senior secured credit facility in determining the present value of lease payments. Operating lease ROU assets exclude lease incentives.
We elected the practical expedient to combine lease and nonlease components. Certain lease agreements contain variable lease payments that do not depend on an index or rate. These variable lease payments are not included in the calculation of the operating lease ROU asset and operating lease liability; instead, they are expensed as incurred. Our leases may contain options to extend or terminate the lease, and we include these terms in our calculation of the operating lease ROU asset and operating lease liability when it is reasonably certain that we will exercise the option.
Operating lease expense is recognized on a straight-line basis over the lease term and recorded within selling, general and administrative expenses on our consolidated statement of operations. In accordance with our accounting policy for impairment of long-lived assets, operating lease ROU assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. We evaluate the recoverability of the asset group based on forecasted undiscounted cash flows. See Note 5 "Leases" for additional information on our leases, including the lease impairment charges recorded in the first nine months of 2019.
3. New Accounting Pronouncements
Recently Adopted
In March 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases, as a new Topic, ASC 842, which superseded ASC Topic 840, Leases, and sets forth the principles for the recognition, measurement, presentation, and disclosure of leases for both lessees and lessors. ASU 2016-02 requires lessees to classify leases as either finance or operating leases and to record on the balance sheet a right-of-use asset and a lease liability, equal to the present value of the remaining lease payments, for all leases with a term greater

5

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

than 12 months regardless of the lease classification. The lease classification will determine whether the lease expense is recognized using an effective interest rate method or on a straight-line basis over the term of the lease. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides an optional transition method that allows entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings on the adoption date. We adopted ASC 842 effective January 1, 2019 on a modified retrospective basis for existing leases using the transition method allowed by ASU 2018-11, which had no impact on our consolidated financial statements in the prior periods presented. The new lease standard had a material impact on our consolidated balance sheet upon adoption but did not impact our consolidated statement of operations. The most significant impact to our consolidated balance sheet is the recognition of ROU assets and lease liabilities for operating leases. The impact of the new lease standard on our consolidated balance sheet upon adoption follows:
 
As of
December 31, 2018
 
ASC 842
Adjustment
 
As of
January 1, 2019
Assets
 
 
 
 
 
Operating lease right-of-use assets
$

 
$
56,463

 
$
56,463

 
 
 
 
 

Liabilities
 
 
 
 
 
Accrued expenses and other current liabilities
$
17,207

 
$
(2,557
)
 
$
14,650

Current maturities of operating lease liabilities
$

 
$
10,537

 
$
10,537

Deferred compensation and other liabilities
$
20,875

 
$
(536
)
 
$
20,339

Deferred lease incentives
$
13,693

 
$
(13,693
)
 
$

Operating lease liabilities, net of current portion
$

 
$
62,712

 
$
62,712


In August 2018, the FASB issued ASU 2018-15, Intangibles - Goodwill and Other - Internal Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This update aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. Capitalized implementation costs are amortized on a straight-line basis generally over the term of the service contract with the amortization recognized in the same financial statement line item as the fees related to the service contract. ASU 2018-15 is effective beginning January 1, 2020, with early adoption permitted. We adopted this ASU in the third quarter of 2019 on a prospective basis. During the third quarter of 2019, we capitalized an immaterial amount of implementation costs for cloud computing arrangements that are service contracts. The future impact of adoption of this ASU on our consolidated financial statements will depend on the magnitude of implementation costs we may incur to implement cloud computing arrangements that are service contracts.
Not Yet Adopted
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which modifies certain disclosure requirements related to fair value measurements. ASU 2018-13 will be effective for us beginning January 1, 2020, with early adoption permitted. We do not expect this guidance to have an impact on the amounts reported on our consolidated financial statements, and we are currently evaluating the potential impact this guidance will have on our disclosures within the notes to our consolidated financial statements.

6

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

4. Goodwill and Intangible Assets
The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the nine months ended September 30, 2019.
 

Healthcare
 

Business
Advisory
 
Education
 
Total
Balance as of December 31, 2018:
 
 
 
 
 
 
 
Goodwill
$
636,810

 
$
301,700

 
$
102,829

 
$
1,041,339

Accumulated impairment losses
(208,081
)
 
(187,995
)
 

 
(396,076
)
Goodwill, net as of December 31, 2018
428,729

 
113,705

 
102,829

 
645,263

Goodwill recorded in connection with a business acquisition (1)

 

 
1,060

 
1,060

Foreign currency translation

 
(337
)
 

 
(337
)
Goodwill, net as of September 30, 2019
$
428,729

 
$
113,368

 
$
103,889

 
$
645,986


(1)
On September 30, 2019, we completed the acquisition of a business in our Education segment. The results of operations of the acquired business is included in our consolidated financial statements and results of operations of our Education segment from the date of acquisition. This acquisition is not significant to our consolidated financial statements.
Intangible Assets
Intangible assets as of September 30, 2019 and December 31, 2018 consisted of the following:
 
 
 
As of September 30, 2019
 
As of December 31, 2018
 
Useful Life 
(in years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Customer relationships
3 to 13
 
$
91,614

 
$
63,109

 
$
98,235

 
$
60,462

Trade names
5 to 6
 
28,930

 
25,215

 
28,930

 
23,181

Technology and software
3 to 5
 
5,694

 
3,951

 
5,694

 
2,842

Non-competition agreements
3 to 5
 
2,515

 
1,607

 
3,650

 
2,241

Customer contracts
2
 
1,270

 

 

 

Favorable lease contract
3
 

 

 
720

 
646

Total
 
 
$
130,023

 
$
93,882

 
$
137,229

 
$
89,372


Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships and customer contracts, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

7

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Intangible asset amortization expense was $4.2 million and $5.9 million for the three months ended September 30, 2019 and 2018, respectively; and $13.0 million and $18.2 million for the nine months ended September 30, 2019 and 2018, respectively. The table below sets forth the estimated annual amortization expense for the year ending December 31, 2019 and each of the five succeeding years for the intangible assets recorded as of September 30, 2019.
Year Ending December 31,
 
Estimated Amortization Expense
2019
 
$
17,484

2020
 
$
12,978

2021
 
$
8,306

2022
 
$
6,114

2023
 
$
3,512

2024
 
$
741

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.
5. Leases
We lease office space, data centers and certain equipment under operating leases expiring on various dates through 2028, with various renewal options that can extend the lease terms by one to ten years. Our operating leases include fixed payments plus, in some cases, scheduled base rent increases over the term of the lease. Certain leases require variable payments of real estate taxes, insurance and operating expenses. We exclude these variable payments from the measurements of our lease liabilities and expense them as incurred. We elected the practical expedient to combine lease and nonlease components. No lease agreements contain any residual value guarantees or material restrictive covenants. As of September 30, 2019, we have not entered into any material finance leases. We sublease certain office spaces to third parties resulting from restructuring activities in certain locations.
Operating lease right-of-use ("ROU") assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset group to which the operating lease ROU asset is assigned may not be recoverable. First, we test the asset group for recoverability by comparing the undiscounted cash flows of the asset group, which include expected future lease and nonlease payments under the lease agreement offset by expected sublease income, to the carrying amount of the asset group. If the first step of the long-lived asset impairment test concludes that the carrying amount of the asset group is not recoverable, we perform the second step of the long-lived asset impairment test by comparing the fair value of the asset group to its carrying amount and recognizing a lease impairment charge for the amount by which the carrying amount exceeds the fair value. To estimate the fair value of the asset group, we rely on a discounted cash flow approach using market participant assumptions of the expected cash flows and discount rate. During the first nine months of 2019, we recorded $0.8 million of lease impairment charges for office spaces vacated in the first nine months of 2019, of which $0.6 million was allocated to the operating lease ROU assets and $0.2 million was allocated to the leasehold improvements based on their relative carrying amounts. The $0.8 million lease impairment charge was recognized in restructuring charges on our consolidated statement of operations. See Note 9 "Restructuring Charges" for additional information on our restructuring activities.
Additional information on our operating leases as of September 30, 2019 follows.
Balance Sheet
 
September 30, 2019
Operating lease right-of-use assets
 
$
52,342

 
 
 
Current maturities of operating lease liabilities
 
$
10,529

Operating lease liabilities, net of current portion
 
59,460

Total lease liabilities
 
$
69,989



8

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Lease Cost
 
Three Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2019
Operating lease cost
 
$
3,036

 
$
9,092

Short-term leases (1)
 
88

 
263

Variable lease costs
 
995

 
3,154

Sublease income
 
(648
)
 
(2,075
)
Net lease cost (2)(3)(4)
 
$
3,471

 
$
10,434

(1)
Includes variable lease costs related to short-term leases.
(2)
Net lease cost includes $0.1 million and $0.3 million for the three and nine months ended September 30, 2019, respectively, recorded as restructuring charges as they relate to vacated office spaces. See Note 9 "Restructuring Charges" for additional information on our vacated office spaces.
(3)
Net lease cost includes $0.1 million and $0.2 million for the three and nine months ended September 30, 2019. respectively, related to vacated office spaces directly related to discontinued operations.
(4)
Rent expense, including operating expenses, real estate taxes and insurance, recorded under ASC 840 for the three and nine months ended September 30, 2018 was $3.7 million and $11.3 million, respectively.
The table below summarizes the remaining expected lease payments under our operating leases as of September 30, 2019 and December 31, 2018.
Future Lease Payments
 
September 30,
2019
 

December 31,
2018 (1, 2)
2019
 
$
3,358

 
$
13,701

2020
 
13,574

 
12,724

2021
 
12,514

 
11,590

2022
 
11,623

 
10,766

2023
 
11,606

 
10,707

Thereafter
 
28,742

 
27,033

Total operating lease payments
 
$
81,417

 
$
86,521

Less: imputed interest
 
(11,428
)
 
n/a

Present value of operating lease liabilities 
 
$
69,989

 
n/a

(1)
The expected lease payments as of December 31, 2018 represent our future minimum rental commitments as defined by ASC 840.
(2)
As of December 31, 2018, the expected total future minimum sublease income to be received was $10.2 million.
Other Information
 
Nine Months Ended
September 30, 2019
Cash paid for operating lease liabilities
 
$
10,504

Operating lease right-of-use assets obtained in exchange for operating lease liabilities
 
$
3,628

 
 
 
Weighted average remaining lease term - operating leases
 
6.6 years

Weighted average discount rate - operating leases
 
4.7
%

During October 2019, we entered into an amendment to the office lease agreement for our principal executive offices in Chicago, Illinois. Among other items, this amendment i) extends the term of the lease from September 30, 2024 to September 30, 2029; ii) provides a renewal option to extend the lease for an additional five year period to September 30, 2034; iii) terminates the lease with respect to certain leased spaces previously vacated; iv) provides abatement of certain future base rent payments and our pro rata share of operating expenses and taxes; and v) provides a one-time cash payment from the lessor as an incentive.

9

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

6. Revenues
For the three months ended September 30, 2019 and 2018, we recognized revenues of $219.3 million and $198.4 million, respectively. Of the $219.3 million recognized in the third quarter of 2019, we recognized revenues of $4.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $3.7 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and $1.1 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $198.4 million recognized in the third quarter of 2018, we recognized revenues of $7.6 million from obligations satisfied, or partially satisfied, in prior periods, of which $4.3 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments and $3.3 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.
For the nine months ended September 30, 2019 and 2018, we recognized revenues of $644.5 million and $589.7 million, respectively. Of the $644.5 million recognized in the first nine months of 2019, we recognized revenues of $2.6 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on unbilled services as a result of securing contract amendments. During the first nine months of 2019, we recognized a $1.4 million decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $589.7 million recognized in the first nine months of 2018, we recognized revenues of $10.1 million from obligations satisfied, or partially satisfied, in prior periods, of which $6.5 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $3.6 million was primarily due to the release of allowances on unbilled services as a result of securing contract amendments.
As of September 30, 2019, we had $47.3 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude obligations under contracts with an original expected duration of one year or less, variable consideration which has been excluded from the total transaction price due to the constraint, and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $47.3 million of performance obligations, we expect to recognize approximately $15.9 million as revenue in 2019, $17.4 million in 2020, and the remaining $14.0 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.
Contract Assets and Liabilities
The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.
Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of September 30, 2019 and December 31, 2018 was $28.6 million and $9.1 million, respectively. The $19.5 million increase primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.
Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of September 30, 2019 and December 31, 2018, was $31.2 million and $28.1 million, respectively. The $3.1 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and nine months ended September 30, 2019, $3.4 million and $21.4 million, respectively, of revenues recognized were included in the deferred revenue balance as of December 31, 2018.

10

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

7. Earnings Per Share
Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, outstanding common stock options, convertible senior notes, and outstanding warrants, to the extent dilutive. Earnings (loss) per share under the basic and diluted computations are as follows: 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Net income from continuing operations
$
13,706

 
$
8,249

 
$
27,625

 
$
10,889

Income (loss) from discontinued operations, net of tax
(52
)
 
228

 
(195
)
 
(304
)
Net income
$
13,654

 
$
8,477

 
$
27,430

 
$
10,585

 
 
 
 
 
 
 
 
Weighted average common shares outstanding – basic
22,052

 
21,745

 
21,973

 
21,683

Weighted average common stock equivalents
509

 
365

 
452

 
264

Weighted average common shares outstanding – diluted
22,561

 
22,110

 
22,425

 
21,947

 
 
 
 
 
 
 
 
Net earnings per basic share:
 
 
 
 

 

Net income from continuing operations
$
0.62

 
$
0.38

 
$
1.26

 
$
0.50

Income (loss) from discontinued operations, net of tax

 
0.01

 
(0.01
)
 
(0.01
)
Net income
$
0.62

 
$
0.39

 
$
1.25

 
$
0.49

 
 
 
 
 
 
 
 
Net earnings per diluted share:
 
 
 
 
 
 
 
Net income from continuing operations
$
0.61

 
$
0.37

 
$
1.23

 
$
0.50

Income (loss) from discontinued operations, net of tax

 
0.01

 
(0.01
)
 
(0.02
)
Net income
$
0.61

 
$
0.38

 
$
1.22

 
$
0.48


The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above were as follows:
 
As of September 30,
 
2019
 
2018
Unvested restricted stock awards

 
11

Convertible senior notes
3,129

 
3,129

Warrants related to the issuance of convertible senior notes
3,129

 
3,129

Total anti-dilutive securities
6,258

 
6,269


See Note 8 “Financing Arrangements” for further information on the convertible senior notes and warrants related to the issuance of convertible notes.
We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the “Share Repurchase Program”). During the fourth quarter of 2019, our board of directors authorized an extension of the Share Repurchase Program through October 31, 2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased during the first nine months of 2019 and 2018. As of September 30, 2019, $35.1 million remains available for share repurchases.

11

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

8. Financing Arrangements
A summary of the carrying amounts of our debt follows:
 
September 30, 2019
 
December 31, 2018
1.25% convertible senior notes due 2019
$
250,000

 
$
242,617

Senior secured credit facility
50,000

 
50,000

Promissory note due 2024
3,982

 
4,368

Total long-term debt
$
303,982

 
$
296,985

Current maturities of long-term debt
(250,525
)
 
(243,132
)
Long-term debt, net of current portion
$
53,457

 
$
53,853


Below is a summary of the scheduled remaining principal payments of our debt as of September 30, 2019.
 
Principal Payments of Long-Term Debt
2019
$
250,130

2020
$
529

2021
$
544

2022
$
559

2023
$
574

Thereafter
$
51,646


Convertible Notes
In September 2014, the Company issued $250 million principal amount of 1.25% convertible senior notes due 2019 (the “Convertible Notes”) in a private offering. The Convertible Notes are governed by the terms of an indenture between the Company and U.S. Bank National Association, as Trustee (the “Indenture”). The Convertible Notes are senior unsecured obligations of the Company and pay interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes matured on October 1, 2019. Upon maturity, we refinanced $217.0 million of the principal amount of the outstanding Convertible Notes with the borrowing capacity available under our revolving credit facility and funded the remaining $33.0 million principal payment with cash on hand.
Prior to maturity, upon conversion, the Convertible Notes would have been settled, at our election, in cash, shares of the Company’s common stock, or a combination of cash and shares of the Company’s common stock. Our intent and policy was to settle conversions with a combination of cash and shares of common stock with the principal amount of the Convertible Notes paid in cash, in accordance with the settlement provisions of the Indenture.
The initial conversion rate for the Convertible Notes was 12.5170 shares of our common stock per $1,000 principal amount of the Convertible Notes, which was equal to an initial conversion price of approximately $79.89 per share of our common stock. The conversion rate would have been subject to adjustment upon the occurrence of certain specified events but would not be adjusted for accrued and unpaid interest, except in certain limited circumstances described in the Indenture. Upon the occurrence of a “make-whole fundamental change” (as defined in the Indenture) the Company would, in certain circumstances, increase the conversion rate by a number of additional shares for a holder that elects to convert its Convertible Notes in connection with such make-whole fundamental change. Additionally, if the Company underwent a “fundamental change” (as defined in the Indenture), a holder had the option to require the Company to repurchase all or a portion of its Convertible Notes for cash at a price equal to 100% of the principal amount of the Convertible Notes being repurchased plus any accrued and unpaid interest. As discussed below, the convertible note hedge transactions and warrants, which were entered into in connection with the Convertible Notes, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share.

12

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Holders of the Convertible Notes had the option to convert the Convertible Notes any time prior to July 1, 2019, only under the following circumstances: 
during any calendar quarter (and only during such calendar quarter) commencing after December 31, 2014 if, for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on, and including, the last trading day of the immediately preceding calendar quarter, the last reported sale price of the Company’s common stock for such trading day was equal to or greater than 130% of the applicable conversion price on such trading day;
during the five consecutive business day period immediately following any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which, for each trading day of the measurement period, the “trading price” (as defined in the Indenture) per $1,000 principal amount of the Convertible Notes for such trading day was less than 98% of the product of the last reported sale price of the Company’s common stock for such trading day and the applicable conversion rate on such trading day; or
upon the occurrence of specified corporate transactions described in the Indenture.
On or after July 1, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder could have converted all or a portion of its Convertible Notes, regardless of the foregoing circumstances.
We have separated the Convertible Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar liability that does not have an associated convertible feature, assuming our non-convertible debt borrowing rate. The carrying value of the equity component representing the conversion option, which is recognized as a debt discount, was determined by deducting the fair value of the liability component from the proceeds of the Convertible Notes. The debt discount was amortized to interest expense using an effective interest rate of 4.751% over the term of the Convertible Notes. The equity component will not be remeasured as long as it continues to meet the conditions for equity classification.
The transaction costs related to the issuance of the Convertible Notes were separated into liability and equity components based on their relative values, as determined above. Transaction costs attributable to the liability component were recorded as a deduction to the carrying amount of the liability and amortized to interest expense over the term of the Convertible Notes; and transaction costs attributable to the equity component were netted with the equity component of the Convertible Notes in stockholders’ equity. Total debt issuance costs were approximately $7.3 million, of which $6.2 million was allocated to liability issuance costs and $1.1 million was allocated to equity issuance costs.
As of September 30, 2019, and December 31, 2018, the Convertible Notes consisted of the following:
 
September 30, 2019
 
December 31, 2018
Liability component:
 
 
 
Proceeds
$
250,000

 
$
250,000

Less: debt discount, net of amortization

 
(6,436
)
Less: debt issuance costs, net of amortization

 
(947
)
Net carrying amount
$
250,000

 
$
242,617

Equity component (1)
$
39,287

 
$
39,287

(1)Included in additional paid-in capital on the consolidated balance sheet.

13

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The following table presents the amount of interest expense recognized related to the Convertible Notes for the periods presented.
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Contractual interest coupon
$
781

 
$
781

 
$
2,344

 
$
2,344

Amortization of debt discount
2,171

 
2,070

 
6,436

 
6,138

Amortization of debt issuance costs
317

 
312

 
947

 
931

Total interest expense
$
3,269

 
$
3,163

 
$
9,727

 
$
9,413


In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions were intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. For purposes of the computation of diluted earnings per share in accordance with GAAP, dilution would occur when the average share price of our common stock for a given period exceeds the conversion price of the Convertible Notes, which initially was equal to approximately $79.89 per share. The convertible note hedge transactions and warrant transactions are discussed separately below. 
Convertible Note Hedge Transactions. In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge transactions whereby the Company had call options to purchase a total of approximately 3.1 million shares of the Company’s common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions were exercisable upon conversion of the Convertible Notes and expired in the third quarter of 2019. We paid an aggregate amount of $42.1 million for the convertible note hedge transactions, which was recorded as additional paid-in capital on the consolidated balance sheet. The convertible note hedge transactions were separate transactions and were not part of the terms of the Convertible Notes.
Warrants. In connection with the issuance of the Convertible Notes, the Company sold warrants whereby the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of the Company’s common stock at a strike price of approximately $97.12. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. We received aggregate proceeds of $23.6 million from the sale of the warrants, which was recorded as additional paid-in capital on the consolidated balance sheet. The warrants are separate transactions and are not part of the terms of the Convertible Notes or the convertible note hedge transactions.
The Company recorded an initial deferred tax liability of $15.4 million in connection with the debt discount associated with the Convertible Notes and recorded an initial deferred tax asset of $16.5 million in connection with the convertible note hedge transactions. The deferred tax liability and deferred tax asset are included in deferred income taxes, net on the consolidated balance sheets.
Senior Secured Credit Facility
On September 27, 2019, we entered into an amendment to the Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Facility"). The Amended Credit Facility provides the Company a $600 million senior secured revolving credit facility, subject to the terms of the Amended Credit Facility, that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. Borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.
Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of

14

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

LIBOR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (as amended, the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 upon the occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. At September 30, 2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.42 to 1.00 and a Consolidated Interest Coverage Ratio of 15.33 to 1.00.
Borrowings outstanding under the Amended Credit Agreement at September 30, 2019 totaled $50.0 million. These borrowings carried a weighted average interest rate of 3.3%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." Borrowings outstanding under the Amended Credit Agreement at December 31, 2018 were $50.0 million and carried a weighted average interest rate of 3.7%, including the effect of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity." The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At September 30, 2019, we had outstanding letters of credit totaling $1.5 million, which are primarily used as security deposits for our office facilities. As of September 30, 2019, the unused borrowing capacity under the revolving credit facility was $548.5 million.
On October 1, 2019, we refinanced $217.0 million of the $250 million outstanding principal amount of the Convertible Notes with the borrowing capacity available under our revolving credit facility, which resulted in outstanding borrowings of $267.0 million. As of October 1, 2019, the unused borrowing capacity under the revolving credit facility was $331.5 million and our pro forma Consolidated Leverage Ratio was 2.16 to 1.00.
Promissory Note due 2024
On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At September 30, 2019, the outstanding principal amount of the promissory note was $4.0 million, and the aircraft had a carrying amount of $5.3 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.

15

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

9. Restructuring Charges
Restructuring charges for the three and nine months ended September 30, 2019 were $0.1 million and $2.2 million, respectively. The $0.1 million charge recognized in the third quarter of 2019 primarily related to workforce reductions as we continue to better align resources with market demand. During the nine months ended September 30, 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the operating lease right-of-use asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. The lease impairment charge was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" for additional information on our adoption of ASC 842. See Note 5 "Leases" for additional information on the long-lived asset impairment test. Additionally, during the nine months ended September 30, 2019, we exited the remaining portion of our Middleton, Wisconsin office and an office space in Houston, Texas, resulting in restructuring charges of $0.4 million and $0.1 million, respectively, which primarily consisted of accelerated depreciation on furniture and fixtures in those offices. The restructuring charges for the nine months ended September 30, 2019 also include $0.2 million related to workforce reductions as we continue to better align resources with market demand and $0.2 million related to workforce reductions in our corporate operations.
Restructuring charges netted to an immaterial amount for the three months ended September 30, 2018 and were $2.7 million for the nine months ended September 30, 2018. The restructuring charges incurred in the third quarter of 2018 consisted of a $0.3 million decrease in the accrual of remaining lease payments, net of estimated sublease income, as a result of updated lease assumptions for our San Francisco office vacated in the third quarter of 2017, which was accounted for in accordance with ASC 840, Leases; and a net $0.2 million charge related to workforce reductions to better align resources with market demand. The $2.7 million restructuring charge incurred in the first nine months of 2018 primarily consisted of $1.2 million related to workforce reductions to better align resources with market demand; $0.7 million related to the accrual of remaining lease payments, net of estimated sublease income, and accelerated depreciation on leasehold improvements due to exiting a portion of our Middleton, Wisconsin office in the second quarter of 2018; $0.3 million related to updated lease assumptions for our San Francisco office vacated in the third quarter of 2017; and $0.3 million related to the divestiture of our Middle East practice within the Business Advisory segment in the second quarter of 2018. During the second quarter of 2018, we sold our Middle East practice to a former employee who was the practice leader of that business at the time; and we recorded a $5.9 million loss for the nine months ended September 30, 2018, which is included in other income (expense), net in our consolidated statements of operations. The restructuring charges recorded in the first nine months of 2018 related to office space reductions were accounted for in accordance with ASC 840, Leases.
The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the nine months ended September 30, 2019.
 
Employee Costs
 
Office Space Reductions
 
Total
Balance as of December 31, 2018
$
443

 
$
2,468

 
$
2,911

Adoption of ASC 842 (1)

 
(1,119
)
 
(1,119
)
Balance as of January 1, 2019
443

 
1,349

 
1,792

Additions (2)
500

 
9

 
509

Payments
(852
)
 
(383
)
 
(1,235
)
Adjustments (2)
(16
)
 
(518
)
 
(534
)
Balance as of September 30, 2019
$
75

 
$
457

 
$
532

(1)
Upon adoption of ASC 842 on January 1, 2019, we reclassified the restructuring charge liabilities, which represented the present value of remaining lease payments, net of estimated sublease income, for vacated office spaces from restructuring charge liabilities to operating lease right-of-use assets. See Note 3 "New Accounting Pronouncements" for additional information on the impact of adoption.
(2)
Additions and adjustments exclude non-cash items related to vacated office spaces, such as lease impairment charges and accelerated depreciation on fixed assets, which are recorded as restructuring charges on our consolidated statements of operations.
The $0.5 million restructuring charge liability related to office space reductions at September 30, 2019 is included as a component of accrued expenses and other current liabilities and deferred compensation and other liabilities. The $0.1 million restructuring charge liability related to employee costs at September 30, 2019 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits.

16

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

10. Derivative Instrument and Hedging Activity
On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.900%.
We recognize all derivative instruments as either assets or liabilities at fair value on the balance sheet. We have designated this derivative instrument as a cash flow hedge. Therefore, changes in the fair value of the derivative instrument are recorded to other comprehensive income (“OCI”) and reclassified into interest expense upon settlement. As of September 30, 2019, it was anticipated that $0.1 million of the losses, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.
The table below sets forth additional information relating to the interest rate swap designated as a cash flow hedging instrument as of September 30, 2019 and December 31, 2018.
 
 
Fair Value (Derivative Asset and Liability)
Balance Sheet Location
 
September 30,
2019
 
December 31,
2018
Prepaid expenses and other current assets
 
$

 
$
302

Other non-current assets
 
$

 
$
451

Accrued expenses and other current liabilities
 
$
121

 
$

Deferred compensation and other liabilities
 
$
482

 
$


All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis on our consolidated balance sheet.
We do not use derivative instruments for trading or other speculative purposes. Refer to Note 12 “Other Comprehensive Income (Loss)” for additional information on our derivative instrument.
11. Fair Value of Financial Instruments
Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:
Level 1 Inputs
 
Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
 
 
Level 2 Inputs
 
Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
 
 
Level 3 Inputs
 
Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.


17

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2019 and December 31, 2018.
 
 
Level 1
 
Level 2
 
Level 3
 
Total
September 30, 2019
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
Convertible debt investment
 
$

 
$

 
$
60,943

 
$
60,943

Deferred compensation assets
 

 
25,435

 

 
25,435

Total assets
 
$

 
$
25,435

 
$
60,943

 
$
86,378

Liabilities:
 
 
 
 
 
 
 
 
Interest rate swap
 
$

 
$
603

 
$

 
$
603

Total liabilities
 
$

 
$
603

 
$

 
$
603

December 31, 2018
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
Interest rate swap
 
$

 
$
753

 
$

 
$
753

Convertible debt investment
 

 

 
50,429

 
50,429

Deferred compensation assets
 

 
18,205

 

 
18,205

Total assets
 
$

 
$
18,958

 
$
50,429

 
$
69,387

Liabilities:
 
 
 
 
 
 
 
 
Contingent consideration for business acquisitions
 
$

 
$

 
$
11,441

 
$
11,441

Total liabilities
 
$

 
$

 
$
11,441

 
$
11,441


Interest rate swap: The fair value of our interest rate swap was derived using estimates to settle the interest rate swap agreement, which is based on the net present value of expected future cash flows on each leg of the swap utilizing market-based inputs and a discount rate reflecting the risks involved.
Convertible debt investment: In 2014 and 2015, we invested $27.9 million, in the form of zero coupon convertible debt, in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight Education, a U.S.-based company that partners with leading universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. In the second quarter of 2019, we amended the convertible notes to extend the maturity date by one year. The notes will mature on July 1, 2021, unless converted earlier.
To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.
The convertible debt investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a Monte Carlo simulation model, cash flow projections discounted at a risk-adjusted rate, and certain assumptions related to equity volatility and applicable holding period, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investment on our consolidated balance sheets.
The table below sets forth the changes in the balance of the convertible debt investment for the nine months ended September 30, 2019.
 
 
Convertible Debt Investment
Balance as of December 31, 2018
 
$
50,429

Change in fair value of convertible debt investment
 
10,514

Balance as of September 30, 2019
 
$
60,943


Deferred compensation assets: We have a non-qualified deferred compensation plan (the "Plan") for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker

18

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets on our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.
Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being achieved or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and discount rates, which typically reflect a risk-free rate. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates. The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the nine months ended September 30, 2019.
 
 
Contingent Consideration for Business Acquisitions
Balance as of December 31, 2018
 
$
11,441

Payments
 
(10,041
)
Remeasurement of contingent consideration for business acquisitions
 
(1,506
)
Unrealized loss due to foreign currency translation
 
106

Balance as of September 30, 2019
 
$


Financial assets and liabilities not recorded at fair value are as follows:
Senior Secured Credit Facility
The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 8 “Financing Arrangements” for additional information on our senior secured credit facility.
Promissory Note due 2024
The carrying value of our promissory note due 2024 is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the promissory note bears interest at rates based on current market rates as set forth in the terms of the promissory note. Refer to Note 8 “Financing Arrangements” for additional information on our promissory note due 2024.
Convertible Notes
The carrying amount and estimated fair value of the Convertible Notes are as follows: 
 
September 30, 2019
 
December 31, 2018
 
Carrying
Amount
 
Estimated
Fair Value
 
Carrying
Amount
 
Estimated
Fair Value
1.25% convertible senior notes due 2019
$
250,000

 
$
249,525

 
$
242,617

 
$
242,940


The difference between the $250 million principal amount of the Convertible Notes and the carrying amount shown as of December 31, 2018 represents the unamortized debt discount and issuance costs. As of September 30, 2019, and December 31, 2018, the carrying value of the equity component of $39.3 million was unchanged from the date of issuance. Refer to Note 8 “Financing Arrangements” for additional information on our Convertible Notes. The estimated fair value of the Convertible Notes was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market, which is a Level 2 input, on the last day of trading for the quarters ended September 30, 2019 and December 31, 2018.

19

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

Based on the closing price of our common stock of $61.34 on September 30, 2019, the if-converted value of the Convertible Notes was less than the principal amount.
Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.
12. Other Comprehensive Income (Loss)
The table below sets forth the components of other comprehensive income (loss), net of tax, for the three and nine months ended September 30, 2019 and 2018.
 
Three Months Ended
September 30, 2019
 
Three Months Ended
September 30, 2018
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
$
(630
)
 
$

 
$
(630
)
 
$
(579
)
 
$

 
$
(579
)
Unrealized gain (loss) on investment
$
1,586

 
$
(418
)
 
$
1,168

 
$
(1,151
)
 
$
299

 
$
(852
)
Unrealized gain (loss) on cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
Change in fair value
$
(158
)
 
$
42

 
$
(116
)
 
$
301

 
$
(78
)
 
$
223

Reclassification adjustments into earnings
(46
)
 
13

 
(33
)
 
(23
)
 
6

 
(17
)
Net unrealized gain (loss)
$
(204
)
 
$
55

 
$
(149
)
 
$
278

 
$
(72
)
 
$
206

Other comprehensive income (loss)
$
752

 
$
(363
)
 
$
389

 
$
(1,452
)
 
$
227

 
$
(1,225
)

 
Nine Months Ended
September 30, 2019
 
Nine Months Ended
September 30, 2018
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
 
Before
Taxes
 
Tax
(Expense)
Benefit
 
Net of
Taxes
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
$
(673
)
 
$

 
$
(673
)
 
$
(1,499
)
 
$

 
$
(1,499
)
Unrealized gain on investment
$
10,514

 
$
(2,774
)
 
$
7,740

 
$
6,044

 
$
(1,571
)
 
$
4,473

Unrealized gain (loss) on cash flow hedges:
 
 
 
 
 
 
 
 
 
 
 
Change in fair value
$
(1,164
)
 
$
308

 
$
(856
)
 
$
1,096

 
$
(285
)
 
$
811

Reclassification adjustments into earnings
(192
)
 
50

 
(142
)
 
13

 
(3
)
 
10

Net unrealized gain (loss)
$
(1,356
)
 
$
358

 
$
(998
)
 
$
1,109

 
$
(288
)
 
$
821

Other comprehensive income
$
8,485

 
$
(2,416
)
 
$
6,069

 
$
5,654

 
$
(1,859
)
 
$
3,795


The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.
Accumulated other comprehensive income, net of tax, includes the following components: 
 
Foreign Currency
Translation
 
Available-for-Sale Investment
 
Cash Flow Hedges
 
Total
Balance, December 31, 2018
$
(665
)
 
$
16,584

 
$
576

 
$
16,495

Current period change
(673
)
 
7,740

 
(998
)
 
6,069

Balance, September 30, 2019
$
(1,338
)
 
$
24,324

 
$
(422
)
 
$
22,564



20

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

13. Income Taxes
For the three months ended September 30, 2019, our effective tax rate was 15.0% as we recognized income tax expense from continuing operations of $2.4 million on income from continuing operations of $16.1 million. The effective tax rate of 15.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to a discrete tax benefit of $0.7 million for U.S. federal return to provision adjustments related to the 2018 corporate income tax return, which had a favorable impact of 4.6% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 4.6% on the effective tax rate. For the three months ended September 30, 2018, our effective tax rate was 14.4% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $9.6 million. The effective tax rate of 14.4% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to a discrete tax benefit of $0.8 million for U.S. federal return to provision adjustments related to the 2017 corporate income tax return, which had a favorable impact of 8.6% on the effective tax rate. In addition, the third quarter of 2018 included a discrete tax benefit of $0.4 million for foreign return to provision adjustments, which had a favorable impact of 3.7% on the effective tax rate.
For the nine months ended September 30, 2019, our effective tax rate was 20.8% as we recognized income tax expense from continuing operations of $7.3 million on income from continuing operations of $34.9 million. The effective tax rate of 20.8% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $1.0 million of discrete tax benefit recognized primarily in the third quarter of 2019 related to U.S. federal and foreign return to provision adjustments, which had a favorable impact of 2.8% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit in the third quarter of 2019 related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 2.1% on the effective tax rate. For the nine months ended September 30, 2018, our effective tax rate was 28.6% as we recognized income tax expense from continuing operations of $4.4 million on income from continuing operations of $15.3 million. The effective tax rate of 28.6% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to discrete tax expense of $1.2 million for share-based compensation awards that vested during the first quarter of 2018, which had an unfavorable impact of 8.1% on the effective tax rate. This unfavorable discrete item was partially offset by a $0.9 million discrete tax benefit recorded in the third quarter of 2018 related to U.S. federal and foreign return to provision adjustments, which had a favorable impact of 6.1% on the effective tax rate.
As of September 30, 2019, we had $0.1 million of unrecognized tax benefits which would affect the effective tax rate of continuing operations if recognized.
14. Commitments, Contingencies and Guarantees
Litigation
During the nine months ended September 30, 2018, we reached a settlement agreement related to Huron's claim in a class action lawsuit, resulting in a gain of $2.5 million.
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
Guarantees
Guarantees in the form of letters of credit totaling $1.5 million and $1.6 million were outstanding at September 30, 2019 and December 31, 2018, respectively, primarily to support certain office lease obligations.
In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of September 30, 2019, the total estimated fair value of our contingent consideration liabilities was zero. As of December 31, 2018, the total estimated fair value of our contingent consideration liabilities was $11.4 million.
To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates

21

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.
15. Segment Information
Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our chief executive officer, manages the business under three operating segments, which are our reportable segments: Healthcare, Business Advisory, and Education.
Healthcare
Our Healthcare segment has a depth of expertise in care transformation, financial and operational excellence, technology and analytics, and leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise to deliver better consumer outcomes.
We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational change and who transform the consumer experience.
Business Advisory
Our Business Advisory segment provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals provide strategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.
Education
Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.
Segment operating income consists of the revenues generated by a segment, less the direct costs of revenue and selling, general and administrative expenses that are incurred directly by the segment. Unallocated corporate costs include costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs

22

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

include costs for corporate office support, certain office facility costs, costs relating to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.
The table below sets forth information about our operating segments for the three and nine months ended September 30, 2019 and 2018, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Healthcare:
 
 
 
 
 
 
 
Revenues
$
100,000

 
$
90,417

 
$
295,621

 
$
271,812

Operating income
$
32,863

 
$
26,640

 
$
94,058

 
$
78,172

Segment operating income as a percentage of segment revenues
32.9
%
 
29.5
%
 
31.8
%
 
28.8
%
Business Advisory:
 
 
 
 
 
 
 
Revenues
$
62,519

 
$
57,175

 
$
183,602

 
$
170,790

Operating income
$
11,942

 
$
11,815

 
$
32,997

 
$
35,031

Segment operating income as a percentage of segment revenues
19.1
%
 
20.7
%
 
18.0
%
 
20.5
%
Education:
 
 
 
 
 
 
 
Revenues
$
56,770

 
$
50,856

 
$
165,265

 
$
147,069

Operating income
$
14,413

 
$
15,014

 
$
43,235

 
$
37,694

Segment operating income as a percentage of segment revenues
25.4
%
 
29.5
%
 
26.2
%
 
25.6
%
Total Company:
 
 
 
 
 
 
 
Revenues
$
219,289

 
$
198,448

 
$
644,488

 
$
589,671

Reimbursable expenses
23,636

 
21,296

 
65,787

 
59,648

Total revenues and reimbursable expenses
$
242,925

 
$
219,744

 
$
710,275

 
$
649,319


 
 
 
 
 
 
 
Segment operating income
$
59,218

 
$
53,469

 
$
170,290

 
$
150,897

Items not allocated at the segment level:
 
 
 
 
 
 
 
Other operating expenses
32,310

 
30,460

 
105,369

 
94,585

Litigation and other losses (gains), net
(630
)
 
887

 
(1,571
)
 
(4,990
)
Depreciation and amortization
6,962

 
8,561

 
21,285

 
26,281

Other expense, net
4,456

 
3,921

 
10,326

 
19,767

Income from continuing operations before taxes
$
16,120

 
$
9,640

 
$
34,881

 
$
15,254



23

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

The following table illustrates the disaggregation of revenues by billing arrangements, employee types, and timing of revenue recognition, including a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three and nine months ended September 30, 2019 and 2018.
 
Three Months Ended September 30, 2019
 
Healthcare
 
Business Advisory
 
Education
 
Total
Billing Arrangements
 
 
 
 
 
 
 
Fixed-fee
$
65,610

 
$
24,333

 
$
12,418

 
$
102,361

Time and expense
12,307

 
35,212

 
39,688

 
87,207

Performance-based
16,313

 
1,614

 

 
17,927

Software support, maintenance and subscriptions
5,770

 
1,360

 
4,664

 
11,794

Total
$
100,000


$
62,519


$
56,770


$
219,289

 
 
 
 
 
 
 
 
Employee Type (1)
 
 
 
 
 
 
 
Revenue generated by full-time billable consultants
$
72,142

 
$
60,131

 
$
48,928

 
$
181,201

Revenue generated by full-time equivalents
27,858

 
2,388

 
7,842

 
38,088

Total
$
100,000


$
62,519


$
56,770


$
219,289

 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
Revenue recognized over time
$
98,204

 
$
62,519

 
$
56,274

 
$
216,997

Revenue recognized at a point in time
1,796

 

 
496

 
2,292

Total
$
100,000

 
$
62,519


$
56,770

 
$
219,289

 
Nine Months Ended September 30, 2019
 
Healthcare
 
Business Advisory
 
Education
 
Total
Billing Arrangements
 
 
 
 
 
 
 
Fixed-fee
$
188,875

 
$
72,693

 
$
37,926

 
$
299,494

Time and expense
39,345

 
104,325

 
114,122

 
257,792

Performance-based
50,144

 
2,810

 

 
52,954

Software support, maintenance and subscriptions
17,257

 
3,774

 
13,217

 
34,248

Total
$
295,621

 
$
183,602

 
$
165,265

 
$
644,488

 
 
 
 
 
 
 
 
Employee Type (1)
 
 
 
 
 
 
 
Revenue generated by full-time billable consultants
$
206,508

 
$
177,279

 
$
144,338

 
$
528,125

Revenue generated by full-time equivalents
89,113

 
6,323

 
20,927

 
116,363

Total
$
295,621

 
$
183,602

 
$
165,265

 
$
644,488

 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
Revenue recognized over time
$
289,452

 
$
183,602

 
$
164,164

 
$
637,218

Revenue recognized at a point in time
6,169

 

 
1,101

 
7,270

Total
$
295,621

 
$
183,602

 
$
165,265

 
$
644,488


24

Table of Contents

HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

 
Three Months Ended September 30, 2018
 
Healthcare
 
Business Advisory
 
Education
 
Total
Billing Arrangements
 
 
 
 
 
 
 
Fixed-fee
$
60,462

 
$
24,129

 
$
9,259

 
$
93,850

Time and expense
15,723

 
32,197

 
37,654

 
85,574

Performance-based
8,372

 
(60
)
 

 
8,312

Software support, maintenance and subscriptions
5,860

 
909

 
3,943

 
10,712

Total
$
90,417

 
$
57,175

 
$
50,856

 
$
198,448

 
 
 
 
 
 
 
 
Employee Type (1)
 
 
 
 
 
 
 
Revenue generated by full-time billable consultants
$
62,409

 
$
54,379

 
$
44,876

 
$
161,664

Revenue generated by full-time equivalents
28,008

 
2,796

 
5,980

 
36,784

Total
$
90,417

 
$
57,175

 
$
50,856

 
$
198,448

 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
Revenue recognized over time
$
88,372

 
$
57,175

 
$
50,104

 
$
195,651

Revenue recognized at a point in time
2,045

 

 
752

 
2,797

Total
$
90,417

 
$
57,175

 
$
50,856

 
$
198,448

 
Nine Months Ended September 30, 2018
 
Healthcare
 
Business Advisory
 
Education
 
Total
Billing Arrangements
 
 
 
 
 
 
 
Fixed-fee
$
182,491

 
$
70,103

 
$
28,699

 
$
281,293

Time and expense
42,755

 
94,357

 
108,019

 
245,131

Performance-based
27,776

 
3,117

 

 
30,893

Software support, maintenance and subscriptions
18,790

 
3,213

 
10,351

 
32,354

Total
$
271,812

 
$
170,790

 
$
147,069

 
$
589,671

 
 
 
 
 
 
 
 
Employee Type (1)
 
 
 
 
 
 
 
Revenue generated by full-time billable consultants
$
183,820

 
$
162,564

 
$
128,613

 
$
474,997

Revenue generated by full-time equivalents
87,992

 
8,226

 
18,456

 
114,674

Total
$
271,812

 
$
170,790

 
$
147,069

 
$
589,671

 
 
 
 
 
 
 
 
Timing of Revenue Recognition
 
 
 
 
 
 
 
Revenue recognized over time
$
266,320

 
$
170,790

 
$
144,118

 
$
581,228

Revenue recognized at a point in time
5,492

 

 
2,951

 
8,443

Total
$
271,812

 
$
170,790

 
$
147,069

 
$
589,671

(1)
Full-time billable consultants consist of our full-time professionals who provide consulting services to our clients and are billable to our clients based on the number of hours worked. Full-time equivalent professionals consist of leadership coaches and their support staff within our Healthcare Leadership solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.
At September 30, 2019 and December 31, 2018, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, net. During the three and nine months ended September 30, 2019 and 2018, no single client generated greater than 10% of our consolidated revenues.

25

Table of Contents




ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.
Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates, and the number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2018 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.
OVERVIEW
Our Business
Huron is a global consultancy that helps clients drive growth, enhance performance and sustain leadership in the markets they serve. We partner with clients to develop strategies and implement solutions that enable the transformative change our clients need to own their future.
We provide professional services through three operating segments: Healthcare, Business Advisory, and Education.
Healthcare
Our Healthcare segment has a depth of expertise in care transformation, financial and operational excellence, technology and analytics, and leadership development. We serve national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. Our solutions help clients evolve and adapt to the rapidly changing healthcare environment and achieve growth, optimize performance, enhance profitability, improve quality and clinical outcomes, align leaders, improve organizational culture, and drive physician, patient, and employee engagement across the enterprise to deliver better consumer outcomes.
We help organizations transform and innovate their delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health. Our consultants partner with clients to help build and sustain today’s business to invest in the future by reducing complexity, improving operational efficiency and growing market share. We enable the healthcare of the future by identifying, integrating and optimizing technology investments to collect data that transforms care delivery and improves patient outcomes. We also develop future leaders capable of driving meaningful operational and organizational change and who transform the consumer experience.
Business Advisory
Our Business Advisory segment provides services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks and private equity firms. We assist clients in a broad range of industries and across the spectrum from healthy, well-capitalized companies to organizations in transition, as well as creditors, equity owners, and other key constituents. Our Business Advisory professionals resolve complex business issues and enhance client enterprise value through a suite of services including capital advisory, transaction advisory, operational improvement, restructuring and turnaround, valuation, and dispute advisory. Our Enterprise Solutions and Analytics professionals deliver technology and analytic solutions that enable organizations to manage and optimize their financial performance, operational efficiency, and client or stakeholder experience. Our Strategy and Innovation professionals collaborate with clients across a range of industries to identify new growth opportunities, build new ventures and capabilities, and accelerate organizational change. Our Life Sciences professionals provide strategic solutions to help pharmaceutical, medical device, and biotechnology companies deliver more value to patients, payers, and providers, and comply with regulations.

26

Table of Contents




Education
Our Education segment provides consulting and technology solutions to higher education institutions and academic medical centers. We partner with clients to address challenges relating to business and technology strategy, financial management, operational and organizational effectiveness, research administration, and regulatory compliance. Our institutional strategy, market research, budgeting and financial management, business operations and student life cycle management solutions align missions with business priorities, improve quality and reduce costs institution-wide. Our student solutions improve attraction, retention and graduation rates, increase student satisfaction and help generate quality outcomes. Our technology strategy, enterprise applications, and analytic solutions transform and optimize operations, deliver time and cost savings, and enhance the student experience. Our research enterprise solutions assist clients in identifying and implementing institutional research strategy, optimizing clinical research operations, improving financial management and cost reimbursement, improving service to faculty, and mitigating risk compliance.
Huron is a Platinum level member of the Oracle PartnerNetwork, an Oracle Cloud Premier Partner within North America, a Workday Services Partner, and a Gold level consulting partner with Salesforce.com.
How We Generate Revenues
A large portion of our revenues is generated by our full-time consultants who provide consulting services to our clients and are billable to our clients based on the number of hours worked. A smaller portion of our revenues is generated by our other professionals, also referred to as full-time equivalents, some of whom work variable schedules as needed by our clients. Full-time equivalent professionals consist of our leadership coaches and their support staff from our Healthcare Leadership solution, specialized finance and operational consultants, and our employees who provide software support and maintenance services to our clients. We translate the hours that these other professionals work on client engagements into a full-time equivalent measure that we use to manage our business. We refer to our full-time consultants and other professionals collectively as revenue-generating professionals.
Revenues generated by our full-time consultants are primarily driven by the number of consultants we employ and their utilization rates, as well as the billing rates we charge our clients. Revenues generated by our other professionals, or full-time equivalents, are largely dependent on the number of consultants we employ, their hours worked, and billing rates charged. Revenues generated by our leadership coaches are largely dependent on the number of coaches we employ and the total value, scope, and terms of the consulting contracts under which they provide services, which are primarily fixed-fee contracts.
We generate our revenues from providing professional services under four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.
In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. It is the client’s expectation in these engagements that the pre-established fee will not be exceeded except in mutually agreed upon circumstances. We generally recognize revenues under fixed-fee billing arrangements using a proportionate performance approach, which is based on work completed to-date versus our estimates of the total services to be provided under the engagement. Contracts within our Healthcare Leadership solution include fixed-fee partner contracts with multiple performance obligations, which primarily consist of coaching services, as well as speaking engagements, conferences, publications and software products (“Partner Contracts”). Revenues for coaching services and software products are generally recognized on a straight-line basis over the length of the contract. All other revenues under Partner Contracts, including speaking engagements, conferences and publications, are recognized at the time the goods or services are provided.
Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software. Licenses for our revenue cycle management software are sold only as a component of our consulting projects, and the services we provide are essential to the functionality of the software. Therefore, revenues from these software licenses are recognized over the term of the related consulting services contract. License revenue from our research administration and compliance software is generally recognized in the month in which the software is delivered.
Fixed-fee engagements represented 46.7% and 47.3% of our revenues for the three months ended September 30, 2019 and 2018, respectively, and 46.5% and 47.7% of our revenues for the nine months ended September 30, 2019 and 2018, respectively.
Time-and-expense billing arrangements require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include certain speaking engagements, conferences and publications purchased by our clients outside of Partner Contracts within our Healthcare Leadership solution. We recognize revenues under time-and-expense billing arrangements as the related services or publications are provided. Time-and-expense engagements represented 39.7% and 43.1% of our revenues for the three months ended September 30, 2019 and 2018, respectively, and 40.0% and 41.6% of our revenues for the nine months ended September 30, 2019 and 2018, respectively.
In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a

27

Table of Contents




result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we have performance-based engagements in which we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our fixed-fee or time-and-expense engagements. We recognize revenues under performance-based billing arrangements by estimating the amount of variable consideration that is probable of being earned and recognizing that estimate over the length of the contract using a proportionate performance approach. Performance-based fee revenues represented 8.2% and 4.2% of our revenues for the three months ended September 30, 2019 and 2018, respectively, and 8.2% and 5.2% of our revenues for the nine months ended September 30, 2019 and 2018, respectively. The level of performance-based fees earned may vary based on our clients' risk sharing preferences and the mix of services we provide.
Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are billed in advance and included in deferred revenues until recognized. Software support, maintenance and subscription revenues represented 5.4% of our revenues for both the three months ended September 30, 2019 and 2018, and 5.3% and 5.5% of our revenues for the nine months ended September 30, 2019 and 2018, respectively.
Our quarterly results are impacted principally by our full-time consultants’ utilization rate, the bill rates we charge our clients, and the number of our revenue-generating professionals who are available to work. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.
Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.
Business Strategy, Opportunities and Challenges
Our primary strategy is to meet the needs of our clients by providing a balanced portfolio of service offerings and capabilities so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve this, we continue to hire highly qualified professionals and have entered into select acquisitions of complementary businesses.
To expand our business, we will remain focused on growing our existing relationships and developing new relationships, executing our managing director compensation plan to attract and retain senior practitioners, continuing to promote and provide an integrated approach to service delivery, broadening the scope of our existing services, and acquiring complementary businesses. We will regularly evaluate the performance of our practices to ensure our investments meet these objectives. Furthermore, we intend to enhance our visibility in the marketplace by refining our overarching messaging and value propositions for the organization as well as each practice. We will continue to focus on reaching our client base through clear, concise, and endorsed messages.

28

Table of Contents




RESULTS OF OPERATIONS
The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data.
Segment and Consolidated Operating Results
(in thousands, except per share amounts):
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Healthcare:
 
 
 
 
 
 
 
 
Revenues
 
$
100,000

 
$
90,417

 
$
295,621

 
$
271,812

Operating income
 
$
32,863

 
$
26,640

 
$
94,058

 
$
78,172

Segment operating income as a percentage of segment revenues
 
32.9
%
 
29.5
%
 
31.8
%
 
28.8
%
Business Advisory:
 
 
 
 
 
 
 
 
Revenues
 
$
62,519

 
$
57,175

 
$
183,602

 
$
170,790

Operating income
 
$
11,942

 
$
11,815

 
$
32,997

 
$
35,031

Segment operating income as a percentage of segment revenues
 
19.1
%
 
20.7
%
 
18.0
%
 
20.5
%
Education:
 
 
 
 
 
 
 
 
Revenues
 
$
56,770

 
$
50,856

 
$
165,265

 
$
147,069

Operating income
 
$
14,413

 
$
15,014

 
$
43,235

 
$
37,694

Segment operating income as a percentage of segment revenues
 
25.4
%
 
29.5
%
 
26.2
%
 
25.6
%
Total Company:
 
 
 
 
 
 
 
 
Revenues
 
$
219,289

 
$
198,448

 
$
644,488

 
$
589,671

Reimbursable expenses
 
23,636

 
21,296

 
65,787

 
59,648

Total revenues and reimbursable expenses
 
$
242,925

 
$
219,744

 
$
710,275

 
$
649,319

Statements of Operations reconciliation:
 
 
 
 
 
 
 
 
Segment operating income
 
$
59,218

 
$
53,469

 
$
170,290

 
$
150,897

Items not allocated at the segment level:
 
 
 
 
 
 
 
 
Other operating expenses
 
32,310

 
30,460

 
105,369

 
94,585

Litigation and other losses (gains), net
 
(630
)
 
887

 
(1,571
)
 
(4,990
)
Depreciation and amortization
 
6,962

 
8,561

 
21,285

 
26,281

Operating income
 
20,576

 
13,561

 
45,207

 
35,021

Other expense, net
 
(4,456
)
 
(3,921
)
 
(10,326
)
 
(19,767
)
Income from continuing operations before taxes
 
16,120

 
9,640

 
34,881

 
15,254

Income tax expense
 
2,414

 
1,391

 
7,256

 
4,365

Net income from continuing operations
 
$
13,706

 
$
8,249

 
$
27,625

 
$
10,889

Earnings per share from continuing operations:
 
 
 
 
 
 
 
 
Basic
 
$
0.62

 
$
0.38

 
$
1.26

 
$
0.50

Diluted
 
$
0.61

 
$
0.37

 
$
1.23

 
$
0.50




29

Table of Contents




 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
Other Operating Data:
 
2019
 
2018
 
2019
 
2018
Number of full-time billable consultants (at period end) (1):
 
 
 
 
 
 
 
 
Healthcare
 
886

 
829

 
886

 
829

Business Advisory
 
954

 
775

 
954

 
775

Education
 
727

 
618

 
727

 
618

Total
 
2,567

 
2,222

 
2,567

 
2,222

Average number of full-time billable consultants (for the period) (1):
 
 
 
 
 
 
 
 
Healthcare
 
858

 
821

 
835

 
802

Business Advisory
 
920

 
735

 
876

 
761

Education
 
698

 
607

 
665

 
579

Total
 
2,476

 
2,163

 
2,376

 
2,142

Full-time billable consultant utilization rate (2):
 
 
 
 
 
 
 
 
Healthcare
 
81.8
%
 
81.2
%
 
80.4
%
 
81.6
%
Business Advisory
 
72.0
%
 
74.4
%
 
72.7
%
 
71.7
%
Education
 
75.5
%
 
77.3
%
 
76.7
%
 
76.8
%
Total
 
76.3
%
 
77.8
%
 
76.5
%
 
76.8
%
Full-time billable consultant average billing rate per hour (3):
 
 
 
 
 
 
 
 
Healthcare
 
$
226

 
$
211

 
$
225

 
$
205

Business Advisory (4)
 
$
193

 
$
213

 
$
195

 
$
212

Education
 
$
197

 
$
205

 
$
200

 
$
203

Total (4)
 
$
206

 
$
210

 
$
207

 
$
207

Revenue per full-time billable consultant (in thousands):
 
 
 
 
 
 
 
 
Healthcare
 
$
84

 
$
76

 
$
247

 
$
229

Business Advisory
 
$
65

 
$
74

 
$
202

 
$
214

Education
 
$
70

 
$
74

 
$
217

 
$
222

Total
 
$
73

 
$
75

 
$
222

 
$
222

Average number of full-time equivalents (for the period) (5):
 
 
 
 
 
 
 
 
Healthcare
 
217

 
228

 
237

 
215

Business Advisory
 
19

 
28

 
14

 
23

Education
 
52

 
40

 
44

 
41

Total
 
288

 
296

 
295

 
279

Revenue per full-time equivalent (in thousands):
 
 
 
 
 
 
 
 
Healthcare
 
$
128

 
$
123

 
$
375

 
$
409

Business Advisory
 
$
126

 
$
99

 
$
465

 
$
355

Education
 
$
151

 
$
149

 
$
480

 
$
447

Total
 
$
132

 
$
124

 
$
395

 
$
410

(1)
Consists of our full-time professionals who provide consulting services and generate revenues based on the number of hours worked.
(2)
Utilization rate for our full-time billable consultants is calculated by dividing the number of hours our full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days.
(3)
Average billing rate per hour for our full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period.
(4)
The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $221 and $241 for the three months ended September 30, 2019 and 2018, respectively; and $220 and $242 for the nine months ended September 30, 2019 and 2018, respectively.
Absent the impact of Huron Eurasia India, Huron's consolidated average billing rate per hour would have been $216 and $218 for the three months ended September 30, 2019 and 2018, respectively; and $216 for both the nine months ended September 30, 2019 and 2018.
(5)
Consists of leadership coaches and their support staff within the Healthcare Leadership solution, consultants who work variable schedules as needed by our clients, and full-time employees who provide software support and maintenance services to our clients.

30

Table of Contents




Non-GAAP Measures
We also assess our results of operations using certain non-GAAP financial measures. These non-GAAP financial measures differ from GAAP because the non-GAAP financial measures we calculate to measure earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.
Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.
The reconciliations of these financial measures from GAAP to non-GAAP are as follows (in thousands, except per share amounts): 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Revenues
$
219,289

 
$
198,448

 
$
644,488

 
$
589,671

Net income from continuing operations
$
13,706

 
$
8,249

 
$
27,625

 
$
10,889

Add back:
 
 
 
 
 
 
 
Income tax expense
2,414

 
1,391

 
7,256

 
4,365

Interest expense, net of interest income
4,374

 
4,628

 
13,156

 
14,636

Depreciation and amortization
8,124

 
9,570

 
24,735

 
29,476

Earnings before interest, taxes, depreciation and amortization (EBITDA)
28,618

 
23,838


72,772

 
59,366

Add back:
 
 
 
 
 
 
 
Restructuring charges
127

 
(31
)
 
2,156

 
2,665

Litigation and other losses (gains), net
(630
)
 
887

 
(1,571
)
 
(4,990
)
Loss on sale of business

 
32

 

 
5,863

Transaction-related expenses
563

 

 
2,613

 

Foreign currency transaction losses, net
114

 
9

 
36

 
196

Adjusted EBITDA
$
28,792

 
$
24,735


$
76,006

 
$
63,100

Adjusted EBITDA as a percentage of revenues
13.1
%
 
12.5
%

11.8
%
 
10.7
%

31

Table of Contents




 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2019
 
2018
 
2019
 
2018
Net income from continuing operations
$
13,706

 
$
8,249

 
$
27,625

 
$
10,889

Weighted average shares - diluted
22,561

 
22,110

 
22,425

 
21,947

Diluted earnings per share from continuing operations
$
0.61

 
$
0.37

 
$
1.23

 
$
0.50

Add back:
 
 
 
 
 
 
 
Amortization of intangible assets
4,205

 
5,934

 
13,036

 
18,233

Restructuring charges
127

 
(31
)
 
2,156

 
2,665

Litigation and other losses (gains), net
(630
)
 
887

 
(1,571
)
 
(4,990
)
Non-cash interest on convertible notes
2,171

 
2,070

 
6,436

 
6,138

Loss on sale of business

 
32

 

 
5,863

Transaction-related expenses
563

 

 
2,613

 

Tax effect of adjustments
(1,673
)
 
(2,312
)
 
(5,909
)
 
(7,109
)
Tax benefit related to the enactment of Tax Cut and Jobs Act of 2017

 
(747
)
 

 
(615
)
Tax benefit related to "check-the-box" election
(736
)
 

 
(736
)
 

Total adjustments, net of tax
4,027

 
5,833

 
16,025

 
20,185

Adjusted net income from continuing operations
$
17,733

 
$
14,082

 
$
43,650

 
$
31,074

Weighted average shares - diluted
22,561

 
22,110

 
22,425

 
21,947

Adjusted diluted earnings per share from continuing operations
$
0.79

 
$
0.64

 
$
1.95

 
$
1.42

These non-GAAP financial measures include adjustments for the following items:
Amortization of intangible assets: We have excluded the effect of amortization of intangible assets from the calculation of adjusted net income from continuing operations presented above. Amortization of intangible assets is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.
Restructuring charges: We have incurred charges due to the restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and severance charges. We have excluded the effect of the restructuring charges from our non-GAAP measures because the amount of each restructuring charge is significantly affected by the timing and size of the restructured business or component of a business.
Litigation and other losses (gains), net: We have excluded the effects of litigation and other losses (gains), net which primarily consist of net remeasurement losses and gains related to contingent acquisition liabilities and the litigation settlement gain recorded in the second quarter of 2018 to permit comparability with periods that were not impacted by these items.
Non-cash interest on convertible notes: We incur non-cash interest expense relating to the implied value of the equity conversion component of our Convertible Notes. The value of the equity conversion component is treated as a debt discount and amortized to interest expense over the life of the Convertible Notes using the effective interest rate method. We exclude this non-cash interest expense that does not represent cash interest payments from the calculation of adjusted net income from continuing operations as management believes that this non-cash expense is not indicative of the ongoing performance of our business.
Loss on sale of business: We excluded the effect of the loss on the sale of the Middle East practice within the Business Advisory segment in the second quarter of 2018. Divestitures of businesses are infrequent and are not indicative of the ongoing performance of our business.
Transaction-related expenses: To permit comparability with prior periods, we excluded the impact of transaction-related expenses for acquisitions, whether or not ultimately consummated, and which primarily relate to third-party legal and accounting fees. The transaction-related expenses incurred in the three and nine months ended September 30, 2019 primarily related to the evaluation of a potential acquisition that ultimately did not consummate.
Foreign currency transaction losses, net: We have excluded the effect of foreign currency transaction losses from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.
Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.
Tax benefit related to the enactment of Tax Cuts and Jobs Act of 2017 ("2017 Tax Reform"): We have excluded the impact of the 2017 Tax Reform, which was enacted in the fourth quarter of 2017. In the first quarter of 2018, we recorded an adjustment to our estimated one-time income tax expense related to the transition tax on accumulated foreign earnings; and in the third quarter of 2018, we recorded a U.S. federal return to provision

32

Table of Contents




adjustment related to 2017 Tax Reform items on our 2017 corporate tax return. The exclusion of the 2017 Tax Reform impact permits comparability with periods that were not impacted by this item.
Tax benefit related to "check-the-box" election: We have excluded the positive impact of a tax benefit, recorded in the third quarter of 2019, from recognizing a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes. The exclusion of this discrete tax benefit permits comparability with periods that were not impacted by this item. Refer to Note 13 "Income Taxes" within the notes to the consolidated financial statements for additional information.
Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We have excluded the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items.
Three Months Ended September 30, 2019 Compared to Three Months Ended September 30, 2018
Revenues
Revenues increased $20.8 million, or 10.5%, to $219.3 million for the third quarter of 2019 from $198.4 million for the third quarter of 2018. Of the overall $20.8 million increase in revenues, $19.5 million was attributable to an increase in revenues from our full-time billable consultants and $1.3 million was attributable to an increase in revenues from our full-time equivalents.
The increase in full-time billable consultant revenues reflected strengthened demand for services in all of our segments, as discussed below in Segment Results, and was primarily attributable to an increase in the average number of billable consultants, partially offset by a decrease in the consultant utilization rate and average billing rate for the third quarter of 2019 compared to the same prior year period.
The increase in full-time equivalent revenues was primarily attributable to our Education segment, as discussed below in Segment Results; and reflected an increase in revenue per full-time equivalent; partially offset by a decrease in the average number of full-time equivalents for the third quarter of 2019 compared to the same prior year period.
Total Direct Costs
Our total direct costs, including amortization of intangible assets and software development costs, increased $14.6 million, or 11.3%, to $144.2 million in the three months ended September 30, 2019, from $129.6 million in the three months ended September 30, 2018. The $14.6 million increase primarily related to a $9.9 million increase in salaries and related expenses for our revenue-generating professionals, which was largely driven by increased headcount in our Business Advisory and Education segments; a $3.7 million increase in performance bonus expense for our revenue-generating professionals; and a $1.5 million increase in share-based compensation expense for our revenue-generating professionals. These increases were partially offset by a $0.5 million decrease in signing, retention and other bonus expense for our revenue-generating professionals. As a percentage of revenues, our total direct costs increased to 65.8% during the third quarter of 2019 compared to 65.3% during the third quarter of 2018, primarily due to the increases in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as percentages of revenues, partially offset by the decrease in signing, retention and other bonus expense for our revenue-generating professionals and revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals.
Total direct costs for the three months ended September 30, 2019 included $1.2 million of amortization expense for internal software development costs and intangible assets, compared to $1.0 million of amortization expense for the same prior year period. The $0.2 million increase in amortization expense was primarily attributable to an increase in amortization for internal software development costs. Intangible asset amortization included within direct costs for the three months ended September 30, 2019 and 2018 primarily related to technology and software, certain customer relationships and customer contracts acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on our intangible assets.
Operating Expenses and Other Losses (Gains), Net
Selling, general and administrative expenses increased by $2.2 million, or 4.8%, to $48.1 million in the third quarter of 2019 from $45.9 million in the third quarter of 2018. The overall $2.2 million increase primarily related to a $1.2 million increase in share-based compensation expense for our support personnel; a $1.0 million increase in computer and related equipment expenses; and a $0.6 million increase in legal expenses. These increases were partially offset by a $0.8 million decrease in travel and entertainment expenses. As a percentage of revenues, selling, general and administrative expenses decreased to 21.9% during the third quarter of 2019 compared to 23.1% during the third quarter of 2018. This decrease was primarily attributable to revenue growth that outpaced an increase in salaries and related expenses for our support personnel, as well as decreases in travel and entertainment expenses and facilities expense. These decreases were partially offset by the increases in share-based compensation expense for our support personnel and computer and related equipment expenses, as percentages of revenues.
Restructuring charges for the third quarter of 2019 were $0.1 million and netted to an immaterial amount for the third quarter of 2018.The $0.1 million charge recognized in the third quarter of 2019 primarily related to workforce reductions as we continue to better align resources with market demand.

33

Table of Contents




The restructuring charges incurred in the third quarter of 2018 consisted of a $0.3 million decrease in the accrual of remaining lease payments, net of estimated sublease income, as a result of updated lease assumptions for our San Francisco office vacated in the third quarter of 2017, which was accounted for in accordance with ASC 840, Leases; and a net $0.2 million charge related to workforce reductions to better align resources with market demand. See Note 9 "Restructuring Charges" within the notes to our consolidated financial statements for additional information on our restructuring charges.
Litigation and other losses (gains), net totaled a gain of $0.6 million for the third quarter of 2019, and consisted of remeasurement gains to decrease the estimated fair value of our liabilities for contingent consideration payments related to a business acquisition. Litigation and other losses (gains), net totaled a net loss of $0.9 million for the third quarter of 2018, and consisted of net remeasurement losses to increase the estimated fair value of contingent consideration liabilities. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. See Note 11 "Fair Value of Financial Instruments" within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.
Depreciation and amortization expense decreased $1.6 million, or 18.7%, to $7.0 million in the three months ended September 30, 2019 compared to $8.6 million in the three months ended September 30, 2018. The $1.6 million decrease in depreciation and amortization expense was primarily attributable to decreasing amortization expense of the trade name and customer relationships acquired in our Studer Group acquisition, due to the accelerated basis of amortization in prior periods, as well as certain customer relationships acquired in other business acquisitions that were fully amortized in prior periods. Intangible asset amortization expense included within operating expenses primarily related to certain customer relationships, trade names, and non-competition agreements acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information on our intangible assets.
Operating Income
Operating income increased $7.0 million to $20.6 million in the third quarter of 2019 from $13.6 million in the third quarter of 2018. Operating margin, which is defined as operating income expressed as a percentage of revenues, was 9.4% in the three months ended September 30, 2019, compared to 6.8% in the three months ended September 30, 2018. The increase in operating margin was primarily attributable to the decrease in intangible asset amortization, revenue growth that outpaced the increase in salaries and related expenses for our support personnel, and the decrease in litigation and other losses (gains), net; partially offset by the increases in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as percentages of revenues.
Other Expense, Net
Total other expense, net increased $0.5 million to $4.5 million in the third quarter of 2019 from $3.9 million in the third quarter of 2018. The increase in other expense, net was primarily attributable to the immaterial gain recognized during the first nine months of 2019 for the market value of our investments that are used to fund our deferred compensation liability, compared to a gain of $0.7 million recognized during the third quarter of 2018, partially offset by a decrease in interest expense, net of interest income recognized in the third quarter of 2019 compared to the third quarter of 2018. Interest expense, net of interest income decreased $0.3 million to $4.4 million in the third quarter of 2019 from $4.6 million in the third quarter of 2018. The decrease in interest expense was due to lower levels of borrowing under our credit facility, partially offset by higher interest rates during the third quarter of 2019 compared to the third quarter of 2018.
Income Tax Expense
For the three months ended September 30, 2019, our effective tax rate was 15.0% as we recognized income tax expense from continuing operations of $2.4 million on income from continuing operations of $16.1 million. The effective tax rate of 15.0% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to a discrete tax benefit of $0.7 million for U.S. federal return to provision adjustments related to the 2018 corporate income tax return, which had a favorable impact of 4.6% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 4.6% on the effective tax rate. For the three months ended September 30, 2018, our effective tax rate was 14.4% as we recognized income tax expense from continuing operations of $1.4 million on income from continuing operations of $9.6 million. The effective tax rate of 14.4% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to a discrete tax benefit of $0.8 million for U.S. federal return to provision adjustments related to the 2017 corporate income tax return, which had a favorable impact of 8.6% on the effective tax rate. In addition, the third quarter of 2018 included a discrete tax benefit of $0.4 million for foreign return to provision adjustments, which had a favorable impact of 3.7% on the effective tax rate.

34

Table of Contents




Net Income from Continuing Operations
Net income from continuing operations increased $5.5 million to $13.7 million for the three months ended September 30, 2019 from $8.2 million for the same period last year. As a result of the increase in net income from continuing operations, diluted income per share from continuing operations for the third quarter of 2019 was $0.61 compared to $0.37 for the third quarter of 2018.
EBITDA and Adjusted EBITDA
EBITDA increased $4.8 million to $28.6 million for the three months ended September 30, 2019 from $23.8 million for the three months ended September 30, 2018. Adjusted EBITDA increased $4.1 million to $28.8 million in the third quarter of 2019 from $24.7 million in the third quarter of 2018. The increases in EBITDA and adjusted EBITDA were primarily attributable to the increase in revenues for the third quarter of 2019 compared to the third quarter of 2018, partially offset by the increases in selling, general and administrative expenses, salaries and related expenses for our revenue-generating professionals, and performance bonus expense for our revenue-generating professionals.
Adjusted Net Income from Continuing Operations
Adjusted net income from continuing operations increased $3.7 million to $17.7 million in the third quarter of 2019 compared to $14.1 million in the third quarter of 2018. As a result of the increase in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations was $0.79 for the third quarter of 2019, compared to $0.64 for the third quarter of 2018.
Segment Results
Healthcare
Revenues
Healthcare segment revenues increased $9.6 million, or 10.6%, to $100.0 million for the third quarter of 2019 from $90.4 million for the third quarter of 2018.
During the three months ended September 30, 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 65.6%, 12.3%, 16.3%, and 5.8% of this segment’s revenues, respectively, compared to 66.8%, 17.4%, 9.3%, and 6.5% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was $16.3 million for the third quarter of 2019 compared to $8.4 million for the third quarter of 2018. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.
The overall $9.6 million increase in revenues was attributable to an increase in revenues from our full-time billable consultants. The increase in revenues attributable to our full-time billable consultants reflected increases in the average billing rate, the average number of billable consultants and the consultant utilization rate in the third quarter of 2019 compared to the same prior year period.
Operating Income
Healthcare segment operating income increased $6.2 million, or 23.4%, to $32.9 million for the three months ended September 30, 2019 from $26.6 million for the three months ended September 30, 2018. The Healthcare segment operating margin, defined as segment operating income expressed as a percentage of segment revenues, increased to 32.9% for the third quarter of 2019 from 29.5% in the same period last year. The increase in this segment’s operating margin was primarily attributable to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and support personnel, as well as decreases in contractor expense and restructuring charges; partially offset by an increase in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as a percentage of revenues.
Business Advisory
Revenues
Business Advisory segment revenues increased $5.3 million, or 9.3%, to $62.5 million for the third quarter of 2019 from $57.2 million for the third quarter of 2018.
During the three months ended September 30, 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 38.9%, 56.3%, 2.6%, and 2.2% of this segment’s revenues, respectively. During the three months ended September 30, 2018, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 42.2%, 56.3%, and 1.5% of this segment's revenues, respectively, for the same prior year period. Performance-based fee revenue was $1.6 million for the third quarter of 2019 and was immaterial for the third quarter of 2018. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.

35

Table of Contents




Of the overall $5.3 million increase in revenues, $5.8 million was attributable to an increase in revenues from our full-time billable consultants; partially offset by a $0.4 million decrease in revenues generated by our full-time equivalents. The increase in revenues from our full-time billable consultants reflected an increase in the average number of billable consultants, partially offset by decreases in the average billing rate and the consultant utilization rate in the third quarter of 2019 compared to the same prior year period. The decrease in revenues generated by our full-time equivalents was driven by a decreased use of contractors; and reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the third quarter of 2019 compared to the same prior year period.
Operating Income
Business Advisory segment operating income increased by $0.1 million, or 1.1%, to $11.9 million for the three months ended September 30, 2019 from $11.8 million for the three months ended September 30, 2018. The Business Advisory segment operating margin decreased to 19.1% for the third quarter of 2019 from 20.7% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries and related expenses, performance bonus expense and share-based compensation expense for our revenue-generating professionals, all as percentages of revenues; partially offset by decreases in signing, retention and other bonus expense for our revenue-generating professionals, practice and administration expenses, and contractor expense.
Education
Revenues
Education segment revenues increased $5.9 million, or 11.6%, to $56.8 million for the third quarter of 2019 from $50.9 million for the third quarter of 2018.
During the three months ended September 30, 2019, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 21.9%, 69.9%, and 8.2% of this segment’s revenues, respectively, compared to 18.2%, 74.0%, and 7.8% of this segment’s revenues, respectively, for the same prior year period.
Of the overall $5.9 million increase in revenues, $4.1 million was attributable to our full-time billable consultants and $1.9 million was attributable to our full-time equivalents. The increase in revenues attributable to our full-time billable consultants reflected an increase in the average number of full-time billable consultants, partially offset by decreases in the average billing rate and the consultant utilization rate in the third quarter of 2019 compared to the same prior year period. The increase in revenues from our full-time equivalents was primarily driven by an increase in software and data hosting revenues; and reflected increases in the average number of full-time equivalents and revenue per full-time equivalent in the third quarter of 2019 compared to the same prior year period.
Operating Income
Education segment operating income decreased $0.6 million, or 4.0%, to $14.4 million for the three months ended September 30, 2019 from $15.0 million for the three months ended September 30, 2018. The Education segment operating margin decreased to 25.4% for the third quarter of 2019 from 29.5% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to increases in salaries and related expenses for our revenue generating professionals; contractor expense; share-based compensation expense and performance bonus expense for our revenue-generating professionals; and promotion and marketing expense, all as percentages of revenues.
Nine Months Ended September 30, 2019 Compared to Nine Months Ended September 30, 2018
Revenues
Revenues increased $54.8 million, or 9.3%, to $644.5 million for the first nine months of 2019 from $589.7 million for the first nine months of 2018. Of the overall $54.8 million increase in revenues, $53.1 million was attributable to an increase in revenues from our full-time billable consultants and $1.7 million was attributable to our full-time equivalents.
The increase in full-time billable consultant revenues was attributable to strengthened demand for services in all of our segments, as discussed below in Segment Results; and reflected an overall increase in the average number of full-time billable consultants during the first nine months of 2019 compared to the same prior year period.
The increase in full-time equivalent revenues was attributable to increases in full-time equivalent revenues in our Education and Healthcare segments, largely offset by a decrease in full-time equivalent revenues in our Business Advisory segment, as discussed below in Segment Results; and reflected an overall increase in the average number of full-time equivalents, partially offset by an overall decrease in revenue per full-time equivalent.
Total Direct Costs
Our total direct costs, including amortization of intangible assets and software development costs, increased $33.7 million, or 8.6%, to $425.9 million for the nine months ended September 30, 2019, from $392.2 million for the nine months ended September 30, 2018. The overall $33.7 million

36

Table of Contents




increase primarily related to an $18.2 million increase in salaries and related expenses for our revenue-generating professionals, which was largely driven by increased headcount in our Education and Business Advisory segments; an $11.5 million increase in performance bonus expense for our revenue-generating professionals; a $2.9 million increase in share-based compensation expense for our revenue-generating professionals; and a $1.2 million increase in contractor expense. As a percentage of revenues, our total direct costs decreased to 66.1% during the first nine months of 2019 compared to 66.5% during the first nine months of 2018 primarily due to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals, partially offset by the increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Total direct costs for the nine months ended September 30, 2019 included $3.5 million of amortization expense for internal software development costs and intangible assets, compared to $3.2 million of amortization expense for the same prior year period. The $0.3 million increase in amortization expense was attributable to a $0.9 million increase in amortization for internal software development costs, partially offset by a $0.6 million decrease in intangible asset amortization attributable to certain intangible assets acquired in our Studer Group acquisition which were fully amortized in prior periods. Intangible asset amortization included within direct costs for the nine months ended September 30, 2019 and 2018 related to technology and software, certain customer relationships, publishing content and customer contracts acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.
Operating Expenses and Other Losses (Gains), Net
Selling, general and administrative expenses increased $12.9 million, or 9.3%, to $151.4 million in the nine months ended September 30, 2019, from $138.5 million in the nine months ended September 30, 2018. The overall $12.9 million increase primarily related to a $5.0 million increase in salaries and related expenses for our support personnel; a $2.4 million increase in share-based compensation expense for our support personnel; a $2.3 million increase in computer and related equipment expenses; a $1.9 million increase in legal expenses; and a $0.7 million increase in performance bonus expense for our support personnel. The increase in legal fees was primarily due to third-party transaction-related expenses related to the evaluation of a potential acquisition that ultimately did not consummate. As a percentage of revenues, selling, general and administrative expenses was 23.5% for both the first nine months of 2019 and 2018.
Restructuring charges for the first nine months of 2019 totaled $2.2 million, compared to $2.7 million for the first nine months of 2018. During the first quarter of 2019, we exited a portion of our Lake Oswego, Oregon corporate office resulting in a $0.7 million lease impairment charge on the related operating lease right-of-use ("ROU") asset and leasehold improvements and $0.2 million of accelerated depreciation on furniture and fixtures in that office. The lease impairment charge recognized in the first quarter of 2019 was recognized in accordance with ASC 842, Leases, which we adopted on a modified retrospective basis on January 1, 2019. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for additional information on our adoption of ASC 842. See Note 5 "Leases" within the notes to our consolidated financial statements for additional information on the long-lived asset impairment test performed in the first quarter of 2019. In the second quarter of 2019, we exited the remaining portion of our Middleton, Wisconsin office and an office space in Houston, Texas, resulting in restructuring charges of $0.4 million and $0.1 million, respectively, which primarily related to accelerated depreciation on related furniture and fixtures. Additional restructuring charges during the first nine months of 2019 include $0.5 million related to workforce reductions as we continue to better align resources with market demand.
The $2.7 million restructuring charge incurred in the first nine months of 2018 primarily consisted of $1.2 million related to workforce reductions to better align resources with market demand; $0.7 million related to the accrual of remaining lease payments, net of estimated sublease income, and accelerated depreciation on leasehold improvements due to exiting a portion of our Middleton, Wisconsin office in the second quarter of 2018; $0.3 million related to updated lease assumptions for our San Francisco office vacated in the third quarter of 2017; and $0.3 million related to the divestiture of our Middle East practice within the Business Advisory segment in the second quarter of 2018. During the second quarter of 2018, we sold our Middle East practice to a former employee who was the practice leader of that business at the time; and we recorded a $5.9 million loss for the nine months ended September 30, 2018, which is included in other income (expense), net in our consolidated statements of operations. The restructuring charges recorded in the first nine months of 2018 related to office space reductions were accounted for in accordance with ASC 840, Leases. See Note 9 "Restructuring Charges" within the notes to our consolidated financial statements for additional information on our restructuring charges.
Litigation and other losses (gains), net totaled a gain of $1.6 million for the nine months ended September 30, 2019, which primarily consisted of $1.5 million of remeasurement gains to decrease the estimated fair value of our liabilities for contingent consideration payments related to business acquisitions. Litigation and other losses (gains), net totaled a gain of $5.0 million for the nine months ended September 30, 2018, which consisted of a $2.5 million litigation settlement gain for the resolution of Huron's claim in a class action lawsuit in the second quarter of 2018 and $2.5 million of net remeasurement gains to decrease the estimated fair value of our contingent consideration liabilities. In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. See Note 11 "Fair Value of Financial Instruments" within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.

37

Table of Contents




Depreciation and amortization expense decreased by $5.0 million, or 19.0%, to $21.3 million in the nine months ended September 30, 2019, from $26.3 million in the nine months ended September 30, 2018. The decrease was primarily attributable to decreasing amortization expense of the trade name and customer relationships acquired in our Studer Group acquisition and certain customer relationships acquired in other business acquisitions, due to the accelerated basis of amortization in prior periods, as well as certain other customer relationships acquired in business acquisitions that were fully amortized in prior periods. Intangible asset amortization included within operating expenses for the nine months ended September 30, 2019 and 2018 primarily related to certain customer relationships, trade names and non-competition agreements acquired in connection with our business acquisitions. See Note 4 "Goodwill and Intangible Assets" within the notes to our consolidated financial statements for additional information about our intangible assets.
Operating Income
Operating income increased $10.2 million to $45.2 million in the first nine months of 2019 from $35.0 million in the first nine months of 2018. Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to 7.0% for the nine months ended September 30, 2019, compared to 5.9% for the nine months ended September 30, 2018. The increase in operating margin was primarily attributable to the revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and the decrease in intangible asset amortization expense; partially offset by the increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Other Expense, Net
Total other expense, net decreased by $9.4 million to $10.3 million in the first nine months of 2019 from $19.8 million in the first nine months of 2018. The decrease in total other expense, net was primarily attributable to a $5.9 million loss recorded in the first nine months of 2018 related to the divestiture of our Middle East practice within our Business Advisory segment. During the second quarter of 2018, we sold our Middle East business to a former employee who was the practice leader of that business at the time. The decrease in total other expense, net was also attributable to a $2.8 million gain recognized during the first nine months of 2019 for the market value of our investments that are used to fund our deferred compensation liability, compared to a gain of $0.9 million during the first nine months of 2018. Interest expense, net of interest income decreased $1.5 million to $13.2 million in the first nine months of 2019 from $14.6 million in the first nine months of 2018. The decrease in interest expense was due to lower levels of borrowing under our credit facility during the first nine months of 2019 compared to the same prior year period, partially offset by higher interest rates during the first nine months of 2019 compared to the same prior year period.
Income Tax Expense
For the nine months ended September 30, 2019, our effective tax rate was 20.8% as we recognized income tax expense from continuing operations of $7.3 million on income from continuing operations of $34.9 million. The effective tax rate of 20.8% was more favorable than the statutory rate, inclusive of state income taxes, of 26.4% primarily due to $1.0 million of discrete tax benefit recognized primarily in the third quarter of 2019 related to U.S. federal and foreign return to provision adjustments, which had a favorable impact of 2.8% on the effective tax rate. In addition, we recognized a $0.7 million discrete tax benefit in the third quarter of 2019 related to a previously unrecognized tax benefit due to the expiration of statute of limitations on our "check-the-box" election made in 2015 to treat certain wholly-owned foreign subsidiaries as disregarded entities for U.S. federal income tax purposes, which had a favorable impact of 2.1% on the effective tax rate. For the nine months ended September 30, 2018, our effective tax rate was 28.6% as we recognized income tax expense from continuing operations of $4.4 million on income from continuing operations of $15.3 million. The effective tax rate of 28.6% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0% primarily due to discrete tax expense of $1.2 million for share-based compensation awards that vested during the first quarter of 2018, which had an unfavorable impact of 8.1% on the effective tax rate. This unfavorable discrete item was partially offset by a $0.9 million discrete tax benefit recorded in the third quarter of 2018 related to U.S. federal and foreign return to provision adjustments, which had a favorable impact of 6.1% on the effective tax rate.
Net Income from Continuing Operations
Net income from continuing operations increased by $16.7 million to $27.6 million for the nine months ended September 30, 2019, from $10.9 million for the same prior year period. As a result of the increase in net income from continuing operations, diluted earnings per share from continuing operations for the first nine months of 2019 was $1.23 compared to $0.50 for the first nine months of 2018.
EBITDA and Adjusted EBITDA
EBITDA increased $13.4 million to $72.8 million for the nine months ended September 30, 2019, from $59.4 million for the nine months ended September 30, 2018. Adjusted EBITDA increased $12.9 million to $76.0 million in the first nine months of 2019 from $63.1 million in the first nine months of 2018. The increase in EBITDA was primarily attributable to the increase in revenues for the first nine months of 2019 compared to the same prior year period and the loss on the divestiture of our Middle East business within our Business Advisory segment recorded in the first nine months of 2018. These increases to EBITDA were partially offset by the increases in salaries and related expenses for our revenue-generating professionals, selling, general and administrative expenses, and performance bonus expense for our revenue-generating professionals; as well as the decrease in litigation and other gains, net recognized in the first nine months of 2019 compared to the same prior year period. The increase in adjusted EBITDA was primarily attributable to the increase in revenues, partially offset by the increases in salaries and related expenses for our

38

Table of Contents




revenue-generating professionals, selling, general and administrative expenses, and performance bonus expense for our revenue-generating professionals in the first nine months of 2019 compared to the same prior year period.
Adjusted Net Income from Continuing Operations
Adjusted net income from continuing operations increased $12.6 million to $43.7 million in the first nine months of 2019 compared to $31.1 million in the first nine months of 2018. As a result of the increase in adjusted net income from continuing operations, adjusted diluted earnings per share from continuing operations for the first nine months of 2019 was $1.95 compared to $1.42 for the first nine months of 2018.
Segment Results
Healthcare
Revenues
Healthcare segment revenues increased $23.8 million, or 8.8%, to $295.6 million for the first nine months of 2019 from $271.8 million for the first nine months of 2018.
During the nine months ended September 30, 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 63.9%, 13.3%, 17.0%, and 5.8% of this segment’s revenues, respectively, compared to 67.2%, 15.7%, 10.2%, and 6.9% of this segment’s revenues, respectively, for the same prior year period. Performance-based fee revenue was $50.1 million during the first nine months of 2019, compared to $27.8 million during the first nine months of 2018. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.
Of the overall $23.8 million increase in revenues, $22.7 million was attributable to an increase in revenues from our full-time billable consultants and $1.1 million was attributable to our full-time equivalents. The increase in revenues attributable to our full-time billable consultants reflected increases in the average billing rate and the average number of full-time billable consultants, partially offset by a decrease in the consultant utilization rate in the first nine months of 2019 compared to the same prior year period. The increase in revenues attributable to our full-time equivalents reflected an increase in the average number of full-time equivalents, partially offset by a decrease in revenue per full-time equivalent in the first nine months of 2019 compared to the same prior year period.
Operating Income
Healthcare segment operating income increased $15.9 million, or 20.3%, to $94.1 million for the nine months ended September 30, 2019, from $78.2 million for the nine months ended September 30, 2018. The Healthcare segment operating margin increased to 31.8% for the first nine months of 2019 from 28.8% in the same period last year. The increase in this segment’s operating margin was primarily attributable to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals, partially offset by an increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Business Advisory
Revenues
Business Advisory segment revenues increased $12.8 million, or 7.5%, to $183.6 million for the first nine months of 2019 from $170.8 million for the first nine months of 2018.
During the first nine months of 2019, revenues from fixed-fee engagements; time-and-expense engagements; performance-based arrangements; and software support, maintenance and subscription arrangements represented 39.6%, 56.8%, 1.5%, and 2.1% of this segment’s revenues, respectively, compared to 41.0%, 55.3%, 1.8%, and 1.9% of this segment’s revenues, respectively, during the same prior year period. Performance-based fee revenue was $2.8 million for the first nine months of 2019, compared to $3.1 million for the first nine months of 2018. The level of performance-based fees earned may vary based on our clients’ preferences and the mix of services we provide.
Of the overall $12.8 million increase in revenues, $14.7 million was attributable to an increase in revenues from our full-time billable consultants, partially offset by a $1.9 million decrease in revenues attributable to our full-time equivalents. The increase in revenues from our full-time billable consultants was primarily driven by increases in the average number of full-time billable consultants and the consultant utilization rate, partially offset by a decrease in the average billing rate in the first nine months of 2019 compared to the same prior year period. The decrease in revenues from our full-time equivalents was driven by a decreased use of contractors and our part-time project consultants; and reflected a decrease in the average number of full-time equivalents, partially offset by an increase in revenue per full-time equivalent in the first nine months of 2019 compared to the same prior year period.

39

Table of Contents




Operating Income
Business Advisory segment operating income decreased by $2.0 million, or 5.8%, to $33.0 million for the nine months ended September 30, 2019, from $35.0 million for the nine months ended September 30, 2018. The Business Advisory segment operating margin decreased to 18.0% for the first nine months of 2019 from 20.5% in the same period last year. The decrease in this segment’s operating margin was primarily attributable to an increase in performance bonus expense for our revenue-generating professionals, as a percentage of revenues.
Education
Revenues
Education segment revenues increased $18.2 million, or 12.4%, to $165.3 million for the first nine months of 2019 from $147.1 million for the first nine months of 2018.
For the nine months ended September 30, 2019, revenues from fixed-fee engagements; time-and-expense engagements; and software support, maintenance and subscription arrangements represented 22.9%, 69.1%, and 8.0% of this segment’s revenues, respectively, compared to 19.5%, 73.5%, and 7.0% of this segment's revenues, respectively, during the same prior year period.
Of the overall $18.2 million increase in revenues, $15.7 million was attributable to revenues generated by our full-time billable consultants and $2.5 million was attributable to revenues generated by our full-time equivalents. The increase in revenues from our full-time billable consultants reflected an increase in the average number of full-time billable consultants; partially offset by a decrease in the average billing rate in the first nine months of 2019 compared to the same prior year period. The increase in revenues from our full-time equivalents was primarily driven by an increase in software and data hosting revenues; and reflected increases in revenue per full-time equivalent and the average number of full-time equivalents in the first nine months of 2019 compared to the same prior year period.
Operating Income
Education segment operating income increased $5.5 million, or 14.7%, to $43.2 million for the nine months ended September 30, 2019, from $37.7 million for the nine months ended September 30, 2018. The Education segment operating margin increased to 26.2% for the first nine months of 2019 from 25.6% in the same period last year. The increase in this segment’s operating margin was primarily attributable to revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and a decrease in practice administration and meetings expenses; partially offset by an increase in contractor expense, as a percentage of revenues.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents increased $16.3 million to $49.4 million at September 30, 2019 from $33.1 million at December 31, 2018. As of September 30, 2019, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.
 
 
Nine Months Ended
September 30,
Cash Flows (in thousands):
 
2019
 
2018
Net cash provided by operating activities
 
$
51,745

 
$
48,867

Net cash used in investing activities
 
(24,420
)
 
(13,496
)
Net cash used in financing activities
 
(11,060
)
 
(43,141
)
Effect of exchange rate changes on cash
 
38

 
(114
)
Net increase (decrease) in cash and cash equivalents
 
$
16,303

 
$
(7,884
)
Operating Activities
Net cash provided by operating activities totaled $51.7 million for the nine months ended September 30, 2019, compared to of $48.9 million for the nine months ended September 30, 2018, respectively. Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances.
The increase in cash provided by operating activities for the first nine months of 2019 compared to cash provided by operating activities in the same prior year period was primarily attributable to an increase in cash collections from clients for the nine months ended September 30, 2019 compared to the nine months ended September 30, 2018, largely offset by the amount paid for annual performance bonuses during the first quarter of 2019 compared to the first quarter of 2018.

40

Table of Contents




Investing Activities
Net cash used in investing activities was $24.4 million and $13.5 million for the nine months ended September 30, 2019 and 2018, respectively.
The use of cash in the first nine months of 2019 primarily consisted of $10.0 million for purchases of property and equipment, primarily related to purchases of computers and related equipment and leasehold improvements for new office spaces in certain locations; $7.5 million for payments related to internally developed software; $4.4 million for contributions to our life insurance policies which fund our deferred compensation plan; and $2.5 million for the purchase of a business in the third quarter of 2019.
The use of cash in the first nine months of 2018 primarily consisted of $6.7 million for purchases of property and equipment, primarily related to purchases of computers and related equipment; $3.6 million for payments related to internally developed software; $2.4 million for payments related to the divestiture of our Middle East practice within the Business Advisory segment; and $1.7 million for contributions to our life insurance policies which fund our deferred compensation plan.
We estimate that cash utilized for purchases of property and equipment and software development in 2019 will be approximately $20 million to $24 million, primarily consisting of software development costs, leasehold improvements for certain office locations, and information technology related equipment to support our corporate infrastructure.
Financing Activities
Net cash used in financing activities was $11.1 million for the nine months ended September 30, 2019. During the first nine months of 2019, we paid $10.0 million to the sellers of certain business acquisitions for achieving specified financial performance targets in accordance with the related purchase agreements. Of the total $10.0 million payments made, $4.7 million is classified as a cash outflow from financing activities and represents the amount paid up to the fair value of the contingent consideration liability recorded as of the acquisition date. The remaining $5.3 million is classified as a cash outflow from operating activities. During the first nine months of 2019, we borrowed $105.5 million under our credit facility, primarily to fund our annual performance bonus payment, and made repayments on our borrowings of $105.9 million.
Net cash used in financing activities was $43.1 million for the nine months ended September 30, 2018. During the first nine months of 2018, we borrowed $179.8 million under our credit facility and made repayments on our borrowings of $213.7 million. During the first nine months of 2018, we paid $7.8 million to the sellers of certain business acquisitions for achieving specified financial performance targets in accordance with the related purchase agreements. Of the total $7.8 million payments made, $4.9 million is classified as a cash outflow from financing activities and represents the amount paid up to the fair value of the contingent consideration liability recorded as of the acquisition date. The remaining $2.9 million is classified as a cash outflow from operating activities.
Share Repurchase Program
We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the "Share Repurchase Program"). During the fourth quarter of 2019, our board of directors authorized an extension of the Share Repurchase Program through October 31, 2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. No shares were repurchased in the first nine months of 2019 or 2018. As of September 30, 2019, $35.1 million remains available for share repurchases.
Financing Arrangements
At September 30, 2019, we had $250.0 million principal amount of our 1.25% convertible senior notes outstanding, $50.0 million outstanding under our senior secured credit facility, and $4.0 million outstanding under a promissory note, as discussed below.
1.25% Convertible Senior Notes
In September 2014, we issued $250.0 million principal amount of the Convertible Notes in a private offering. The Convertible Notes are senior unsecured obligations of the Company and paid interest semi-annually on April 1 and October 1 of each year at an annual rate of 1.25%. The Convertible Notes matured on October 1, 2019. Upon maturity, we refinanced $217.0 million of the principal amount of the outstanding Convertible Notes with the borrowing capacity available under our revolving credit facility and funded the remaining $33.0 million principal payment with cash on hand.
In connection with the issuance of the Convertible Notes, we entered into convertible note hedge transactions and warrant transactions. The convertible note hedge transactions were intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. The convertible note hedge transactions expired in the third quarter of 2019. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date.

41

Table of Contents




The carrying amount of our Convertible Notes as of September 30, 2019 and December 31, 2018, was $250.0 million and $242.6 million, respectively, which represented the $250.0 million principal amount net of unamortized debt discount and issuance costs. The carrying amount of our Convertible Notes is included in current maturities of long-term debt on the consolidated balance sheet.
For further information, see Note 8 “Financing Arrangements” within the notes to our consolidated financial statements.
Senior Secured Credit Facility
The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.
Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of LIBOR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances. In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 upon the occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. At September 30, 2019, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.42 to 1.00 and a Consolidated Interest Coverage Ratio of 15.33 to 1.00.
The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.25, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $25 million.
Borrowings outstanding under the Amended Credit Agreement at September 30, 2019 totaled $50.0 million. These borrowings carried a weighted average interest rate of 3.3%, including the impact of the interest rate swap in effect as of September 30, 2019 and described in Note 10 “Derivative Instrument and Hedging Activity” within the notes to the consolidated financial statements. Borrowings outstanding under the Amended Credit Agreement at December 31, 2018 were $50.0 million and carried a weighted average interest rate of 3.7%, including the impact of the interest rate swap described in Note 10 “Derivative Instrument and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At September 30, 2019, we had outstanding letters of credit totaling $1.5 million, which are primarily used as security deposits for our office facilities. As of September 30, 2019, the unused borrowing capacity under the revolving credit facility was $548.5 million.
On October 1, 2019, we refinanced $217.0 million of the $250.0 million outstanding principal amount of the Convertible Notes with the borrowing capacity available under our revolving credit facility, which resulted in outstanding borrowings of $267.0 million. As of October 1, 2019, the unused borrowing capacity under the revolving credit facility was $331.5 million and our pro forma Consolidated Leverage Ratio was 2.16 to 1.00.

42

Table of Contents




Promissory Note due 2024
On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed, from the sellers of the aircraft, a promissory note with an outstanding principal balance of $5.1 million. The principal balance of the promissory note is subject to scheduled monthly principal payments until the maturity date of March 1, 2024, at which time a final payment of $1.5 million, plus any accrued and unpaid interest, will be due. Under the terms of the promissory note, we will pay interest on the outstanding principal amount at a rate of one-month LIBOR plus 1.97% per annum. The obligations under the promissory note are secured pursuant to a Loan and Aircraft Security Agreement with Banc of America Leasing & Capital, LLC, which grants the lender a first priority security interest in the aircraft. At September 30, 2019, the outstanding principal amount of the promissory note was $4.0 million, and the aircraft had a carrying amount of $5.3 million. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million, and the aircraft had a carrying amount of $5.8 million.
For further information, see Note 8 “Financing Arrangements” within the notes to the consolidated financial statements.
Future Needs
Our primary financing need has been to fund our growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures. We believe our internally generated liquidity, together with our available cash, the borrowing capacity available under our revolving credit facility, and access to external capital resources will be adequate to fund our long-term growth and capital needs arising from cash commitments and debt service obligations. Our ability to secure short-term and long-term financing in the future will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.
CONTRACTUAL OBLIGATIONS
For a summary of our commitments to make future payments under contractual obligations, see Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations – Contractual Obligations" in our Annual Report on Form 10-K for the year ended December 31, 2018.
On September 27, 2019, we entered into the fourth amendment (the "Fourth Amendment") to the Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Facility"). The Fourth Amendment extended the maturity date from March 23, 2023 to September 27, 2024. In addition, the Fourth Amendment provided for, among other things, i) an increase to the Aggregate Revolving Commitments from $500 million to $600 million; ii) a more favorable pricing structure; iii) unlimited Restricted Payments when the Consolidated Leverage Ratio is less than 3.25 to 1.00, and establishes a base amount of allowable Restricted Payments of $25 million when the Consolidated Leverage Ratio is greater than 3.25 to 1.00; and iv) an increase to the maximum permitted Consolidated Leverage Ratio to 3.75 to 1.00, and provides an additional increase to the maximum permitted Consolidated Leverage Ratio to 4.00 to 1.00 upon the occurrence of certain transactions. Borrowings outstanding under the Amended Credit Agreement at September 30, 2019 totaled $50.0 million.
The capitalized terms above are defined in the Amended Credit Facility or Fourth Amendment, as applicable. Refer to "Liquidity and Capital Resources" and Note 8 "Financing Arrangements" within the notes to the consolidated financial statements for more information on our outstanding borrowings.
During October 2019, we entered into an amendment to the office lease agreement for our principal executive offices in Chicago, Illinois. Among other items, this amendment i) extends the term of the lease from September 30, 2024 to September 30, 2029; ii) terminates the lease with respect to certain leased spaces previously vacated; iii) modifies the future base rent payments; and iv) provides abatement of the future base rent payments from October 1, 2019 through January 15, 2021. The amendment increased the contractual obligations related to our Chicago office lease as of October 1, 2019 by $12.7 million, primarily related to the contractual lease payments for the extended term beyond September 30, 2024.
There have been no other material changes to our contractual obligations since December 31, 2018. See Note 2 "Basis of Presentation and Significant Accounting Policies" and Note 3 "New Accounting Pronouncements" within the notes to our consolidated financial statements for information on our adoption of ASC 842, Leases. See Note 5 "Leases" within the notes to our consolidated financial statements for information on our future lease payments and a reconciliation of those lease payments to our operating lease liabilities recorded on our consolidated balance sheet.
OFF-BALANCE SHEET ARRANGEMENTS
We are not a party to any material off-balance sheet arrangements.
CRITICAL ACCOUNTING POLICIES
Management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported

43

Table of Contents




amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see Item 7. "Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies" in our Annual Report on Form 10-K for the year ended December 31, 2018. There have been no material changes to our critical accounting policies during the first nine months of 2019.
NEW ACCOUNTING PRONOUNCEMENTS
Refer to Note 3 "New Accounting Pronouncements" within the notes to the consolidated financial statements for information on new accounting pronouncements.
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
We are exposed to market risks primarily from changes in interest rates and changes in the market value of our investments.
Market Risk and Interest Rate Risk
The value of our Convertible Notes is exposed to interest rate risk. Generally, the fair value of our fixed interest rate Convertible Notes will increase as interest rates fall and decrease as interest rates rise. In addition, the fair value of our Convertible Notes is affected by our stock price. The carrying value of our Convertible Notes was $250.0 million as of September 30, 2019, which equaled the $250.0 million principal balance due on October 1, 2019. The estimated fair value of our Convertible Notes at September 30, 2019 was $249.5 million, and was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the quarter ended September 30, 2019, which was $99.810 per $100 principal amount. At December 31, 2018, the carrying value of our Convertible Notes was $242.6 million, and the estimated fair value of our Convertible Notes was $242.9 million, which was determined based on the quoted bid price of the Convertible Notes in an over-the-counter market as of the last day of trading for the year ended December 31, 2018, which was $97.176 per $100 principal amount.
Concurrent with the issuance of the Convertible Notes, we entered into separate convertible note hedge and warrant transactions. The convertible note hedge transactions were intended to reduce the potential future economic dilution associated with the conversion of the Convertible Notes and, combined with the warrants, effectively raised the price at which economic dilution would occur from the initial conversion price of approximately $79.89 to approximately $97.12 per share. Under the convertible note hedge transactions, we had the option to purchase a total of approximately 3.1 million shares of our common stock, which is the number of shares initially issuable upon conversion of the Convertible Notes in full, at a price of approximately $79.89, which corresponds to the initial conversion price of the Convertible Notes, subject to customary anti-dilution adjustments substantially similar to those in the Convertible Notes. The convertible note hedge transactions expired in the third quarter of 2019. Under the warrant transactions, the holders of the warrants have the option to purchase a total of approximately 3.1 million shares of our common stock at a price of approximately $97.12. If the average market value per share of our common stock for the reporting period exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share. The warrants will expire incrementally on 100 different dates from January 6, 2020 to May 28, 2020 and are exercisable at each such expiry date.
We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which has variable interest rates tied to LIBOR or an alternate base rate, at our option. At September 30, 2019, we had borrowings outstanding under the credit facility totaling $50.0 million that carried a weighted average interest rate of 3.3%, including the impact of the interest rate swap described below. As of September 30, 2019, these variable rate borrowings were fully hedged against changes in interest rates by the interest rate swap, which had a notional amount of $50.0 million. As our variable rate borrowings were fully hedged as of September 30, 2019, a change in the interest rate would have had no impact on our consolidated financial statements. At December 31, 2018, we had borrowings outstanding under the credit facility totaling $50.0 million that carried a weighted average interest rate of 3.7% including the impact of the interest rate swap described below. As of December 31, 2018, these variable rate borrowings were fully hedged against changes in interest rates by the interest rate swap, which had a notional amount of $50.0 million. As our variable rate borrowings were fully hedged as of December 31, 2018, a change in the interest rate would have had no impact on our consolidated financial statements.
On June 22, 2017, we entered into a forward interest rate swap agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month LIBOR and we pay to the counterparty a fixed rate of 1.900%.
We also have exposure to changes in interest rates associated with the promissory note assumed on June 30, 2017 in connection with our purchase of an aircraft, which has variable interest rates tied to LIBOR. At September 30, 2019, the outstanding principal amount of the promissory note was $4.0 million and carried an interest rate of 4.2%. A hypothetical 100 basis point change in this interest rate would not have a material effect on our

44

Table of Contents




pretax income. At December 31, 2018, the outstanding principal amount of the promissory note was $4.4 million and carried an interest rate of 4.3%. A hypothetical 100 basis point change in the interest rate as of December 31, 2018 would not have had a material effect on our pretax income.
We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure.
We have a non-interest bearing convertible debt investment in a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of September 30, 2019, the fair value of the investment was $60.9 million, with a total cost basis of $27.9 million. At December 31, 2018, the fair value of the investment was $50.4 million, with a total cost basis of $27.9 million.
ITEM 4.
CONTROLS AND PROCEDURES.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of September 30, 2019. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2019, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended September 30, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION 
ITEM 1.
LEGAL PROCEEDINGS.
The information required by this Item is incorporated by reference from Note 14 "Commitments, Contingencies and Guarantees" included in Part I, Item 1 of this Quarterly Report on Form 10-Q. 
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding that, in the current opinion of management, could have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
ITEM 1A.
RISK FACTORS.
See Part 1, Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, which was filed with the Securities and Exchange Commission on February 27, 2019, for a complete description of the material risks we face.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Our Stock Ownership Participation Program, 2012 Omnibus Incentive Plan, and 2004 Omnibus Stock Plan, which was replaced by the 2012 Omnibus Incentive Plan, permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended September 30, 2019, we reacquired 12,657 shares of common stock with a weighted average fair market value of $58.91 as a result of such tax withholdings.
We currently have a share repurchase program permitting us to repurchase up to $125 million of our common stock through October 31, 2019 (the "Share Repurchase Program"). During the fourth quarter of 2019, our board of directors authorized an extension of the Shares Repurchase Program through October 31, 2020. The amount and timing of the repurchases will be determined by management and will depend on a variety of factors, including the trading price of our common stock, capacity under our line of credit, general market and business conditions, and applicable legal requirements. The following table provides information with respect to purchases we made of our common stock during the quarter ended September 30, 2019.

45

Table of Contents




Period
 
Total Number of Shares Purchased (1)
 
Average Price
Paid per Share
 
Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
 
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
July 1, 2019 - July 31, 2019
 
2,489

 
$
50.38

 

 
$
35,143,546

August 1, 2019 - August 31, 2019
 
9,342

 
$
60.91

 

 
$
35,143,546

September 1, 2019 - September 30, 2019
 
826

 
$
62.02

 

 
$
35,143,546

Total
 
12,657

 
$
58.91

 

 
 
(1)
The number of shares repurchased for each period represents shares to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the Share Repurchase Program.
(2)
As of the end of the period.
ITEM 3.
DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4.
MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5.
OTHER INFORMATION.
None.

46

Table of Contents




ITEM 6.
EXHIBITS.
(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q. 
 
 
 
 
 
 
 
 
Incorporated by Reference
Exhibit
Number
 
Exhibit Description
 
Filed
herewith
 
Furnished
herewith
 
Form
 
Period
Ending
 
Exhibit
 
Filing
Date
10.1
 
 
 
 
 
 
8-K
 
 
 
10.1
 
9/16/2019
10.2
 
 
 
 
 
 
8-K
 
 
 
10.1
 
10/3/2019
10.3
 
 
 
 
 
 
8-K
 
 
 
10.1
 
10/16/2019
31.1
 
 
X
 
 
 
 
 
 
 
 
 
 
31.2
 
 
X
 
 
 
 
 
 
 
 
 
 
32.1
 
 
 
 
X
 
 
 
 
 
 
 
 
32.2
 
 
 
 
X
 
 
 
 
 
 
 
 
101.INS
 
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
X
 
 
 
 
 
 
 
 
 
 
101.SCH
 
Inline XBRL Taxonomy Extension Schema Document
 
X
 
 
 
 
 
 
 
 
 
 
101.CAL
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document
 
X
 
 
 
 
 
 
 
 
 
 
101.LAB
 
Inline XBRL Taxonomy Extension Label Linkbase Document
 
X
 
 
 
 
 
 
 
 
 
 
101.PRE
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document
 
X
 
 
 
 
 
 
 
 
 
 
101.DEF
 
Inline XBRL Taxonomy Extension Definition Linkbase Document
 
X
 
 
 
 
 
 
 
 
 
 
104
 
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
 
X
 
 
 
 
 
 
 
 
 
 


47

Table of Contents




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
Huron Consulting Group Inc.
 
 
 
 
(Registrant)
 
 
 
 
Date:
October 29, 2019
 
 
/S/    JOHN D. KELLY
 
 
 
 
John D. Kelly
 
 
 
 
Executive Vice President,
Chief Financial Officer and Treasurer


48
Exhibit


EXHIBIT 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,
PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, James H. Roth, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:    
 
October 29, 2019
 
By:
 
/S/    JAMES H. ROTH
 
 
 
 
 
 
James H. Roth
 
 
 
 
 
 
Chief Executive Officer


Exhibit


EXHIBIT 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,
PURSUANT TO RULE 13a-14(a)/15d-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John D. Kelly, certify that:
1.
I have reviewed this Quarterly Report on Form 10-Q of Huron Consulting Group Inc.;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date:    
 
October 29, 2019
 
By:
 
/S/    JOHN D. KELLY
 
 
 
 
 
 
John D. Kelly
 
 
 
 
 
 
Executive Vice President,
Chief Financial Officer and Treasurer


Exhibit


EXHIBIT 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER,
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Huron Consulting Group Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, James H. Roth, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
Date:    
 
October 29, 2019
 
By:
 
/S/    JAMES H. ROTH
 
 
 
 
 
 
James H. Roth
 
 
 
 
 
 
Chief Executive Officer
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.


Exhibit


EXHIBIT 32.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER,
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Huron Consulting Group Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John D. Kelly, Executive Vice President, Chief Financial Officer and Treasurer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.
Date:    
 
October 29, 2019
 
By:
 
/S/    JOHN D. KELLY
 
 
 
 
 
 
John D. Kelly
 
 
 
 
 
 
Executive Vice President,
Chief Financial Officer and Treasurer
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be considered filed as part of the Form 10-Q.